{
  "Yes": "是",
  "No": "否",
  "Other": "其他",
  "None": "无",
  "General": "一般信息",
  "General_title": "《卡塔赫纳生物安全议定书》缔约方",
  "General_questions0_title": "贵国是否为《卡塔赫纳生物安全议定书》(CPB) 的缔约方？",
  "General_questions1_title": "若贵国对第12个问题回答“否”，那么是否已启动了成为缔约方的任何国家进程？",
  "General_questions2_title": "您可以在此提供更多细节",
  "Article2": "第2条",
  "Article2_title": "第 2 条 –一般规定",
  "Article2_questions0_title": "贵国是否已采取必要的法律、行政和其他措施以执行《议定书》？",
  "Article2_questions0_options0_title": "国内监管框架已完全启动",
  "Article2_questions0_options1_title": "国内监管框架已部分启动",
  "Article2_questions0_options2_title": "仅采取了临时措施",
  "Article2_questions0_options3_title": "仅有一个草案框架",
  "Article2_questions0_options4_title": "未采取任何措施",
  "Article2_questions1_title": "贵国已制定哪些国家生物安全框架执行文书？",
  "Article2_questions1_options0_title": "一部或多部国家生物安全法律",
  "Article2_questions1_options1_title": "一部或多部国家生物安全条例",
  "Article2_questions1_options2_title": "一套或多套生物安全准则",
  "Article2_questions1_options3_title": "间接适用于生物安全的其他法律、条例或准则",
  "Article2_questions1_options4_title": "未制定任何文书",
  "Article2_questions2_title": "贵国是否已经建立了国家生物安全框架运营资金的预算分配机制？",
  "Article2_questions3_title": "贵国是否由常设工作人员管理与国家生物安全框架直接相关的各项职能？",
  "Article2_questions4_title": "若贵国对第 18 个问题回答“是”，贵国共有多少常设工作人员管理与国家生物安全框架直接相关的各项职能？",
  "Article2_questions4_options0_title": "1",
  "Article2_questions4_options1_title": "不到5",
  "Article2_questions4_options2_title": "不到 10 人",
  "Article2_questions4_options3_title": "超过10",
  "Article2_questions5_title": "贵国的生物安全框架/法律/条例/准则是否已提交至生物安全信息交换所 (BCH)？",
  "Article2_questions5_options1_title": "部分",
  "Article2_questions6_title": "贵国可以在此提供有关贵国执行第2条的更多细节：",
  "Article5": "第5条",
  "Article5_title": "第5条 — 药物",
  "Article5_questions0_title": "贵国是否规范了作为药物的改性活生物体的越境转移、处理和使用？",
  "Article5_questions0_options1_title": "是，某种程度上",
  "Article5_questions1_title": "若贵国对第 22 个问题回答“是”，那么这一条信息是否已提交至生物安全信息交换所 (BCH)？",
  "Article5_questions1_options1_title": "部分",
  "Article5_questions2_title": "您可以在此提供贵国执行第5条的更多细节",
  "Article6": "第6条",
  "Article6_title": "第 6 条 – 过境和封闭使用",
  "Article6_questions0_title": "贵国是否规范了改性活生物体的过境？",
  "Article6_questions1_title": "贵国是否规范了改性活生物体的封闭使用？",
  "Article6_questions2_title": "若贵国对第 25 或第 26 个问题回答“是”，那么这一条信息是否已提交至生物安全信息交换所 (BCH)？",
  "Article6_questions2_options1_title": "部分",
  "Article6_questions3_title": "您可以在此提供贵国执行第6条的更多细节:",
  "Articles7-10": "第7至10条",
  "Articles7_10_title": "第7至10条 – 事先知情同意及有意向环境中引入改性活生物体",
  "Articles7_10_questions0_title": "贵国是否已采取法律/条例/行政措施以实施《议定书》的事先知情同意程序？",
  "Articles7_10_questions1_title": "贵国是否已采取符合《议定书》关于越境转移有意引进环境的改性活生物体的国内管制框架？",
  "Articles7_10_questions2_title": "贵国是否已就拟有意向环境中引入改性活生物体的首次有意越境转移建立了决策机制？",
  "Articles7_10_questions3_title": "若贵国对第31个问题回答“是”，那么这一机制是否也适用于并不局限于越境转移而有意向环境中引入改性活生物体的情形？",
  "Articles7_10_questions4_title": "贵国是否已建立了机制，以监测释放到环境中的改性活生物体的潜在影响？",
  "Articles7_10_questions5_title": "贵国是否有能力发现和识别改性活生物体？",
  "Articles7_10_questions5_options1_title": "是，某种程度上",
  "Articles7_10_questions6_title": "贵国是否已为其所管辖的出口者规定了法律要求，在有意越境转移属于事先知情同意程序范围内的改性活生物体之前以书面形式通知进口缔约方的国家主管部门？",
  "Articles7_10_questions7_title": "贵国是否已就通知所载信息的准确性规定了法律要求？",
  "Articles7_10_questions8_title": "贵国是否曾收到过拟有意向环境中引入改性活生物体的有意越境转移的相关申请/通知？",
  "Articles7_10_questions9_title": "贵国是否曾就拟有意向环境中引入改性活生物体的有意越境转移的相关申请/通知做出决定？",
  "Articles7_10_questions10_title": "若贵国对第38个问题回答“是”，那么贵国迄今已核准进口多少种拟有意向环境中引入的改性活生物体？",
  "Articles7_10_questions10_options1_title": "不到5",
  "Articles7_10_questions10_options2_title": "不到 10 人",
  "Articles7_10_questions10_options3_title": "超过10",
  "Articles7_10_questions11_title": "若贵国对第38个问题回答“是”，那么贵国迄今已核准多少种拟有意向环境中引入的非进口改性活生物体？",
  "Articles7_10_questions11_options1_title": "不到5",
  "Articles7_10_questions11_options2_title": "不到 10 人",
  "Articles7_10_questions11_options3_title": "超过10",
  "Articles7_10_questions12_title": "在本报告所述期间内，贵国已收到多少次拟有意向环境中引入改性活生物体的有意越境转移的相关申请/通知？",
  "Articles7_10_questions12_options1_title": "不到5",
  "Articles7_10_questions12_options2_title": "不到 10 人",
  "Articles7_10_questions12_options3_title": "超过10",
  "Articles7_10_questions13_title": "在本报告所述期间内，贵国已就拟有意向环境中引入改性活生物体的有意越境转移做出过几次决定？",
  "Articles7_10_questions13_options1_title": "不到5",
  "Articles7_10_questions13_options2_title": "不到 10 人",
  "Articles7_10_questions13_options3_title": "超过10",
  "Articles7_10_questions14_title": "在就拟有意向环境中引入改性活生物体的有意越境转移所做决定方面，贵国是否曾在越境转移之前收到过出口方或出口者的通知？",
  "Articles7_10_questions14_options0_title": "是，经常",
  "Articles7_10_questions14_options1_title": "仅在某些情况下",
  "Articles7_10_questions15_title": "通知是否载有完整信息（至少载有《卡塔赫纳生物安全议定书》附件一的规定信息）？",
  "Articles7_10_questions15_options0_title": "是，经常",
  "Articles7_10_questions15_options1_title": "仅在某些情况下",
  "Articles7_10_questions16_title": "贵国是否会在收到通知 90 天之内向通知人确认收到？",
  "Articles7_10_questions16_options0_title": "是，经常",
  "Articles7_10_questions16_options1_title": "仅在某些情况下",
  "Articles7_10_questions17_title": "贵国是否会将其决定告知通知人和生物安全信息交换所？",
  "Articles7_10_questions17_options0_title": "是，经常",
  "Articles7_10_questions17_options1_title": "仅在某些情况下",
  "Articles7_10_questions17_options2_title": "在某些情况下仅告知通知人",
  "Articles7_10_questions17_options3_title": "在某些情况下仅告知生物安全信息交换所",
  "Articles7_10_questions18_title": "贵国是否会适时（在270天之内或贵国与通知人所沟通确定的期限内）将其决定告知通知人和生物安全信息交换所？",
  "Articles7_10_questions18_options0_title": "是，经常",
  "Articles7_10_questions18_options1_title": "仅在某些情况下",
  "Articles7_10_questions19_title": "贵国以下类别决定所占的百分比是多少？",
  "Articles7_10_questions19_options0_title": "对改性活生物体准予无条件进口/使用",
  "Articles7_10_questions19_options1_title": "有条件准予进口/使用改性活生物体",
  "Articles7_10_questions19_options2_title": "禁止改性活生物体的进口/使用",
  "Articles7_10_questions19_options3_title": "要求提供更多相关资料",
  "Articles7_10_questions19_options4_title": "告知通知人延期通报决定",
  "Articles7_10_questions20_title": "在贵国准予有条件进口或禁止进口的情形下，是否会就其决定依据向通知人和生物安全信息交换所说明理由？",
  "Articles7_10_questions20_options0_title": "是，经常",
  "Articles7_10_questions20_options1_title": "仅在某些情况下",
  "Articles7_10_questions20_options2_title": "在某些情况下仅告知通知人",
  "Articles7_10_questions20_options3_title": "在某些情况下仅告知生物安全信息交换所",
  "Articles7_10_questions21_title": "贵国可以在此提供有关贵国执行第7-10条的更多细节，在对有意引进环境的改性活生物体的潜在不利影响没有科学上的把握性时，包括措施：",
  "Article11": "第11条",
  "Article11_title": "第11条 – 关于拟直接用作食品或饲料、或用于加工目的的改性活生物体的程序",
  "Article11_questions0_title": "贵国是否采用了具体的法律或条例，用于就拟直接用作食品或饲料、或用于加工目的的改性活生物体的国内用途包括市场投放做出决定？",
  "Article11_questions1_title": "贵国是否就申请者所提供资料的准确性规定了法律要求？",
  "Article11_questions2_title": "贵国是否建立了机制以确保通过生物安全信息交换所与缔约方就可能被越境转移的拟直接用作食品或饲料、或用于加工目的的改性活生物体相关决定进行沟通？",
  "Article11_questions3_title": "贵国是否已就拟直接用作食品或饲料、或用于加工目的的改性活生物体的进口事宜建立了一个决策机制？",
  "Article11_questions4_title": "贵国是否已在未订有监管框架的情况下通过生物安全信息交换所宣布，它将根据《卡塔赫纳生物安全议定书》第11.6条在拟直接用作食品或饲料、或用于加工目的的改性活生物体的首次进口之前做出决定？",
  "Article11_questions5_title": "贵国是否已表明它需要拟直接用作食品或饲料、或用于加工目的的改性活生物体方面的财务和技术援助和能力建设？",
  "Article11_questions6_title": "贵国是否已就拟直接用作食品或饲料、或用于加工目的的改性活生物体（进口或国内用途）做出决定？",
  "Article11_questions7_title": "贵国迄今已核准了多少种拟直接用作食品或饲料、或用于加工目的的改性活生物体？",
  "Article11_questions7_options1_title": "不到5",
  "Article11_questions7_options2_title": "不到 10 人",
  "Article11_questions7_options3_title": "超过10",
  "Article11_questions8_title": "在本报告所述期间内，贵国已就拟直接用作食品或饲料、或用于加工目的的改性活生物体的进口事宜做出过几次决定？",
  "Article11_questions8_options1_title": "不到5",
  "Article11_questions8_options2_title": "不到 10 人",
  "Article11_questions8_options3_title": "超过10",
  "Article11_questions9_title": "在本报告所述期间内，贵国已就拟直接用作食品或饲料、或用于加工目的的改性活生物体的国内用途包括市场投放做出过几次决定？",
  "Article11_questions9_options1_title": "不到5",
  "Article11_questions9_options2_title": "不到 10 人",
  "Article11_questions9_options3_title": "超过10",
  "Article11_questions10_title": "贵国是否已通过生物安全信息交换所，向缔约方通报了它在拟直接用作食品或饲料、或用于加工目的的改性活生物体的进口方面所做的决定？",
  "Article11_questions10_options0_title": "是，经常",
  "Article11_questions10_options1_title": "仅在某些情况下",
  "Article11_questions11_title": "贵国是否已在 15 天之内，通过生物安全信息交换所向缔约方通报了它在拟直接用作食品或饲料、或用于加工目的的改性活生物体的国内用途包括市场投放方面所做的决定？",
  "Article11_questions11_options0_title": "是，经常",
  "Article11_questions11_options1_title": "仅在某些情况下",
  "Article11_questions11_options2_title": "是，但有延误（即超过 15 天）",
  "Article11_questions12_title": "贵国可以在此提供有关贵国执行第11条的更多细节，在对拟直接用作食品或饲料、或用于加工目的的改性活生物体的潜在不利影响没有科学上的把握性时，包括措施：",
  "Article12": "第12条",
  "Article12_title": "第 12 条 – 对决定的复审",
  "Article12_questions0_title": "贵国是否已建立了相关机制用于审查并更改其已就改性活生物体的有意越境转移所作出的决定？",
  "Article12_questions1_title": "贵国是否收到过对决定进行审查的要求？",
  "Article12_questions2_title": "贵国是否审查/更改过就改性活生物体的有意越境转移做出的决定？",
  "Article12_questions2_options0_title": "是，审查过决定",
  "Article12_questions2_options1_title": "是，审查并更改过决定",
  "Article12_questions3_title": "在本报告所述期间内，审查和/或更改过几次就改性活生物体的有意越境转移做出的决定？",
  "Article12_questions3_options1_title": "不到5",
  "Article12_questions3_options2_title": "超过5",
  "Article12_questions4_title": "贵国是否曾将决定的审查和/或更改告知通知人和生物安全信息交换所？",
  "Article12_questions4_options0_title": "是，经常",
  "Article12_questions4_options1_title": "仅在某些情况下",
  "Article12_questions4_options2_title": "在某些情况下仅告知通知人",
  "Article12_questions4_options3_title": "在某些情况下仅告知生物安全信息交换所",
  "Article12_questions5_title": "贵国是否曾将决定的审查和/或更改在30天之内告知通知人和生物安全信息交换所？",
  "Article12_questions5_options0_title": "是，经常",
  "Article12_questions5_options1_title": "仅在某些情况下",
  "Article12_questions5_options2_title": "是，但有延误（即超过 30 天）",
  "Article12_questions6_title": "贵国是否曾向通知人和生物安全信息交换所说明决定的审查和/或更改理由？",
  "Article12_questions6_options0_title": "是，经常",
  "Article12_questions6_options1_title": "仅在某些情况下",
  "Article12_questions6_options2_title": "在某些情况下仅告知通知人",
  "Article12_questions6_options3_title": "在某些情况下仅告知生物安全信息交换所",
  "Article12_questions7_title": "贵国可以在此提供有关贵国执行第 12 条的更多细节：",
  "Article13": "第13条",
  "Article13_title": "第 13 条 – 简化程序",
  "Article13_questions0_title": "贵国是否已就改性活生物体的有意越境转移简化程序建立了应用系统？",
  "Article13_questions1_title": "贵国是否曾应用简化程序？",
  "Article13_questions2_title": "若贵国对第73个问题回答“是”，贵国是否曾通过生物安全信息交换所向缔约方通报适用简化程序的案例？",
  "Article13_questions2_options0_title": "是，经常",
  "Article13_questions2_options1_title": "仅在某些情况下",
  "Article13_questions3_title": "在本报告所述期间内，贵国对多少种改性活生物体应用了简化程序？",
  "Article13_questions3_options1_title": "不到5",
  "Article13_questions3_options2_title": "超过5",
  "Article13_questions4_title": "贵国可以在此提供有关贵国执行第13条的更多细节：",
  "Article14": "第14条",
  "Article14_title": "第 14 条 – 双边、区域及多边协定和安排",
  "Article14_questions0_title": "贵国是否曾订立任何双边、区域及多边协定和安排？",
  "Article14_questions1_title": "若贵国对第77个问题回答“是”，那么贵国是否曾通过生物安全信息交换所向缔约方通报这类协定或安排？",
  "Article14_questions1_options0_title": "是，经常",
  "Article14_questions1_options1_title": "仅在某些情况下",
  "Article14_questions2_title": "若贵国对第77个问题回答“是”，请简要描述所订立协定或安排的范围和目标：",
  "Article14_questions3_title": "贵国可以在此提供有关贵国执行第14条的更多细节：",
  "Article15": "第15条",
  "Article15_title": "第15条 – 风险评估",
  "Article15_questions0_title": "贵国是否已建立机制，用于在就改性活生物体做出决定之前开展风险评估？",
  "Article15_questions1_title": "若贵国对第81个问题回答“是”，那么这一机制是否包括开展风险评估的专家认定程序？",
  "Article15_questions2_title": "贵国是否已在就改性活生物体做出决定之前开展风险评估方面制定了准则？",
  "Article15_questions3_title": "贵国是否已经获得了开展风险评估的必要国内能力？",
  "Article15_questions4_title": "贵国是否已建立了开展风险评估的国内专家培训机制？",
  "Article15_questions5_title": "贵国是否曾就拟有意向环境中引入的某种改性活生物体开展过风险评估？",
  "Article15_questions6_title": "贵国是否曾就拟直接用作食品或饲料、或用于加工目的的某种改性活生物体开展过风险评估？",
  "Article15_questions7_title": "若贵国曾就拟有意向环境中引入的改性活生物体或拟直接用作食品或饲料、或用于加工目的的改性活生物体的国内用途做出过决定，那么是否对所有决定都开展了风险评估？",
  "Article15_questions7_options0_title": "是，经常",
  "Article15_questions7_options1_title": "仅在某些情况下",
  "Article15_questions8_title": "贵国是否曾向生物安全信息交换所提交风险评估总结报告？",
  "Article15_questions8_options0_title": "是，经常",
  "Article15_questions8_options1_title": "仅在某些情况下",
  "Article15_questions9_title": "在本报告所述期间内，若贵国曾就改性活生物体做出过决定，那么在这些决定背景下开展过多少次风险评估？",
  "Article15_questions9_options1_title": "不到5",
  "Article15_questions9_options2_title": "不到 10 人",
  "Article15_questions9_options3_title": "超过10",
  "Article15_questions10_title": "贵国是否曾要求出口者开展风险评估？",
  "Article15_questions10_options0_title": "是，经常",
  "Article15_questions10_options1_title": "仅在某些情况下",
  "Article15_questions11_title": "贵国是否曾要求通知人承担改性活生物体的风险评估费用？",
  "Article15_questions11_options0_title": "是，经常",
  "Article15_questions11_options1_title": "仅在某些情况下",
  "Article15_questions12_title": "贵国可以在此提供有关贵国执行第15条的更多细节：",
  "Article16": "第16条",
  "Article16_title": "第16条 – 风险管理",
  "Article16_questions0_title": "有意引入到环境中的改性活生物体？",
  "Article16_questions0_options1_title": "是，某种程度上",
  "Article16_questions1_title": "拟直接用作食品或饲料、或用于加工目的的改性活生物体",
  "Article16_questions1_options1_title": "是，某种程度上",
  "Article16_questions2_title": "贵国是否制定并保持了适当的措施，以防止改性活生物体的意外越境转移？",
  "Article16_questions2_options1_title": "是，某种程度上",
  "Article16_questions3_title": "贵国是否采取了措施来确保任何改性活生物体（无论是进口的还是本地研制的）在用作预期用途之前均接受与其生命周期或增代时间相应的适当期限的观察？",
  "Article16_questions4_title": "贵国是否与其他缔约方进行合作，以期识别可能对生物多样性保护和可持续利用产生不利影响的改性活生物体或其具体特性？",
  "Article16_questions5_title": "贵国是否与其他缔约方进行了合作，以期采取措施，处理可能对生物多样性保护和可持续利用产生不利影响的改性活生物体或其具体特性？",
  "Article16_questions6_title": "贵国可以在此提供有关贵国执行第16条的更多细节，在对改性活生物体的潜在不利影响没有科学上的把握性时，包括关于风险管理占领的详细情况：",
  "Article17": "第17条",
  "Article17_title": "第 17 条 – 意外越境转移以及紧急措施",
  "Article17_questions0_title": "贵国是否已根据第17条向生物安全信息交换所提供了相关详情，列明其联络点以便接收通知？",
  "Article17_questions1_title": "贵国是否已就可能对生物多样性产生重大不利影响的改性活生物体意外越境转移的紧急措施制定了一个应对机制？",
  "Article17_questions2_title": "贵国是否执行了紧急措施应对有关释放导致或可能导致改性活生物体的意外越境转移的信息？",
  "Article17_questions3_title": "在本报告所述期间内，贵国曾获得过几次有关在贵国管辖范围内出现导致或可能导致一种或多种改性活生物体意外越境转移的事件信息？",
  "Article17_questions3_options0_title": "从来没有",
  "Article17_questions3_options1_title": "不到5",
  "Article17_questions3_options2_title": "不到 10 人",
  "Article17_questions3_options3_title": "超过10",
  "Article17_questions4_title": "贵国是否曾就上述释放情况通知受到影响或可能会受到影响的国家、生物安全信息交换所并酌情通知有关国际组织？",
  "Article17_questions4_options0_title": "是，每次",
  "Article17_questions4_options1_title": "是，有时",
  "Article17_questions5_title": "若贵国对第104个问题回答“是”，那么贵国通知的是：",
  "Article17_questions5_options0_title": "受影响或可能会受影响的国家",
  "Article17_questions5_options1_title": "生物安全信息交换所",
  "Article17_questions5_options2_title": "有关国际组织",
  "Article17_questions6_title": "贵国是否曾立即与受到影响或可能会受到影响的国家进行协商，使之得以确定适当的应对办法并主动采取必要行动，包括采取各种应急措施？",
  "Article17_questions6_options0_title": "是，经常",
  "Article17_questions6_options1_title": "是，有时",
  "Article17_questions6_options2_title": "否，进行了协商，但不及时",
  "Article17_questions6_options3_title": "否，从未进行协商",
  "Article17_questions7_title": "贵国可以在此提供有关贵国执行第17条的更多细节：",
  "Article18": "第18条",
  "Article18_title": "第 18 条 – 处理、运输、包装和标志",
  "Article18_questions0_title": "贵国是否参照有关国际规则和标准，采取措施要求在安全的条件下处理、包装和运输属于拟越境转移的改性活生物体？",
  "Article18_questions0_options1_title": "某种程度上是",
  "Article18_questions1_title": "贵国是否已采取措施，在通过身份保护系统等手段无法获知改性活生物体名称的情况下，要求拟直接用作食品或饲料、或用于加工目的的改性活生物体所附单据明确说明其中“可能含有”改性活生物体且不打算有意将其引入环境，并附上供进一步索取信息资料的联络点。",
  "Article18_questions1_options1_title": "是，某种程度上",
  "Article18_questions2_title": "贵国是否已采取措施，在通过身份保护系统等手段获知改性活生物体名称的情况下，要求拟直接用作食品或饲料、或用于加工目的的改性活生物体所附单据明确说明其中含有改性活生物体且不打算有意将其引入环境之中，并附上供进一步索取信息资料的联络点？",
  "Article18_questions2_options1_title": "是，某种程度上",
  "Article18_questions3_title": "贵国是否已采取措施，要求预定用于封闭性使用的改性活生物体所附单据明确将其标明为改性活生物体，并具体说明安全处理、储存、运输和使用的任何要求，以及供进一步索取信息资料的联络点，包括接收改性活生物体的个人和机构的名称和地址？",
  "Article18_questions3_options1_title": "是，某种程度上",
  "Article18_questions4_title": "贵国是否已采取措施，要求拟有意引入进口缔约方环境中的改性活生物体所附单据明确将其标明为改性活生物体；具体说明其名称和相关特性和/或特点、关于安全处理、储存、运输和使用的任何要求以及供进一步索取信息资料的联络点，并酌情提供进口者和出口者名称和地址；以及列出关于所涉转移符合本议定书中适用于出口者的规定的声明？",
  "Article18_questions4_options1_title": "是，某种程度上",
  "Article18_questions5_title": "贵国是否有能力实施改性活生物体识别和单据方面的要求？",
  "Article18_questions5_options1_title": "某种程度上是",
  "Article18_questions6_title": "贵国是否建立了改性活生物体的采样和检测程序？",
  "Article18_questions6_options1_title": "是，某种程度上",
  "Article18_questions7_title": "贵国可以在此提供有关贵国执行第 18 条的更多细节：",
  "Article19": "第19条",
  "Article19_title": "第 19 条 – 国家主管部门和国家联络点",
  "Article19_questions0_title": "贵国是否指定了《卡塔赫纳议定书》国家联络点负责与秘书处进行联系？",
  "Article19_questions1_title": "贵国是否指定了生物安全信息交换所国家联络点，就生物安全信息交换所的发展和执行方面的问题与秘书处联系？",
  "Article19_questions2_title": "贵国是否已指定了一个或数个国家主管部门，负责行使《卡塔赫纳生物安全议定书》规定的行政职能并按照授权代表贵国行使此类职能？",
  "Article19_questions2_options0_title": "是，一个",
  "Article19_questions2_options1_title": "是，数个",
  "Article19_questions3_title": "若贵国指定了一个以上的国家主管部门，贵国是否已将这些主管部门的各自职责转告了秘书处？",
  "Article19_questions4_title": "贵国是否已向生物安全信息交换所提供了第116－119个问题所提及的必要信息？",
  "Article19_questions4_options0_title": "是，所有信息",
  "Article19_questions4_options1_title": "是，某些信息",
  "Article19_questions5_title": "如果贵国已指定了一个以上的国家主管部门，那么贵国是否已经建立相关机制以在就改性活生物体作出决定之前对所述主管部门的行动进行协调？",
  "Article19_questions6_title": "贵国是否已建立了充分的体制能力，使国家主管部门能够执行《卡塔赫纳生物安全议定书》所要求的行政职能？",
  "Article19_questions6_options1_title": "是，某种程度上",
  "Article19_questions7_title": "贵国可以在此提供有关贵国执行第19条的更多细节：",
  "Article20": "第20条",
  "Article20_title": "第 20 条 – 信息共享与生物安全信息交换所（BCH）",
  "Article20_questions0_title": "用于执行《议定书》的现有的国家立法、条例和准则，以及缔约方用于事先知情同意程序所需要的信息（第 20 条第 3(a) 款）",
  "Article20_questions0_options0_title": "有信息且已向生物安全信息交换所提交",
  "Article20_questions0_options1_title": "有信息但尚未向生物安全信息交换所提交",
  "Article20_questions0_options2_title": "有信息但只向生物安全信息交换所提交了一部分",
  "Article20_questions0_options3_title": "没有信息",
  "Article20_questions1_title": "适用于拟直接用作食品或饲料、或用于加工目的的进口改性活生物体的国家法律、条例和准则（第 11 条第 5 款）",
  "Article20_questions1_options0_title": "有信息且已向生物安全信息交换所提交",
  "Article20_questions1_options1_title": "有信息但尚未向生物安全信息交换所提交",
  "Article20_questions1_options2_title": "有信息但只向生物安全信息交换所提交了一部分",
  "Article20_questions1_options3_title": "没有信息",
  "Article20_questions2_title": "双边、多边及区域协议和安排（第14条第2款和第20条第3（b）款）",
  "Article20_questions2_options0_title": "有信息且已向生物安全信息交换所提交",
  "Article20_questions2_options1_title": "有信息但尚未向生物安全信息交换所提交",
  "Article20_questions2_options2_title": "有信息但只向生物安全信息交换所提交了一部分",
  "Article20_questions2_options3_title": "没有信息",
  "Article20_questions3_title": "国家主管部门（第 19 条第 2 和 3 款）和国家联络点（第 19 条第 1 和 3 款）的详细联系方式以及紧急联系方式（第 17 条第 3(e) 款）",
  "Article20_questions3_options0_title": "有信息且已向生物安全信息交换所提交",
  "Article20_questions3_options1_title": "有信息但尚未向生物安全信息交换所提交",
  "Article20_questions3_options2_title": "有信息但只向生物安全信息交换所提交了一部分",
  "Article20_questions3_options3_title": "没有信息",
  "Article20_questions4_title": "缔约方关于《议定书》的执行提交的报告（第 20 条第 3(e) 款）",
  "Article20_questions4_options0_title": "有信息且已向生物安全信息交换所提交",
  "Article20_questions4_options1_title": "有信息但尚未向生物安全信息交换所提交",
  "Article20_questions4_options2_title": "有信息但只向生物安全信息交换所提交了一部分",
  "Article20_questions4_options3_title": "没有信息",
  "Article20_questions5_title": "某一缔约方对特定改性活生物体的特性予以管制的决定（第 6 条第 1 款）",
  "Article20_questions5_options0_title": "有信息且已向生物安全信息交换所提交",
  "Article20_questions5_options1_title": "有信息但尚未向生物安全信息交换所提交",
  "Article20_questions5_options2_title": "有信息但只向生物安全信息交换所提交了一部分",
  "Article20_questions5_options3_title": "没有信息",
  "Article20_questions6_title": "可能对生物多样性造成重大不利影响的无意的越境转移事件（第 17 条第 1 款）",
  "Article20_questions6_options0_title": "有信息且已向生物安全信息交换所提交",
  "Article20_questions6_options1_title": "有信息但尚未向生物安全信息交换所提交",
  "Article20_questions6_options2_title": "有信息但只向生物安全信息交换所提交了一部分",
  "Article20_questions6_options3_title": "没有信息",
  "Article20_questions7_title": "改性活生物体的非法越境转移（第 25 条第 3 款）",
  "Article20_questions7_options0_title": "有信息且已向生物安全信息交换所提交",
  "Article20_questions7_options1_title": "有信息但尚未向生物安全信息交换所提交",
  "Article20_questions7_options2_title": "有信息但只向生物安全信息交换所提交了一部分",
  "Article20_questions7_options3_title": "没有信息",
  "Article20_questions8_title": "关于改性活生物体进口或释放的最后决定（即批准或禁止、任何先行条件、要求进一步信息、批准延期、决定的理由）（第 10 条第 3 款和第 20 第 3(d) 款）",
  "Article20_questions8_options0_title": "有信息且已向生物安全信息交换所提交",
  "Article20_questions8_options1_title": "有信息但尚未向生物安全信息交换所提交",
  "Article20_questions8_options2_title": "有信息但只向生物安全信息交换所提交了一部分",
  "Article20_questions8_options3_title": "没有信息",
  "Article20_questions9_title": "关于特定改性活生物体进口时国内条例适用性的信息（第14条第4款）",
  "Article20_questions9_options0_title": "有信息且已提交生物安全信息交换所",
  "Article20_questions9_options1_title": "有信息但尚未向生物安全信息交换所提交",
  "Article20_questions9_options2_title": "有信息但只向生物安全信息交换所提交了一部分",
  "Article20_questions9_options3_title": "没有信息",
  "Article20_questions10_title": "关于在国内使用可能越境转移的拟直接用作食品或饲料、或用于加工目的的改性活生物体的最终决定（第 11 条第 1 款）",
  "Article20_questions10_options0_title": "有信息且已向生物安全信息交换所提交",
  "Article20_questions10_options1_title": "有信息但尚未向生物安全信息交换所提交",
  "Article20_questions10_options2_title": "有信息但只向生物安全信息交换所提交了一部分",
  "Article20_questions10_options3_title": "没有信息",
  "Article20_questions11_title": "关于在国内规定框架下（第 11 条第 4 款）或按照附件三（第 11 条第 6 款）（第 20 条第 3(d) 款的要求）进口拟直接用作食品或饲料、或用于加工目的的改性活生物体的最终决定",
  "Article20_questions11_options0_title": "有信息且已向生物安全信息交换所提交",
  "Article20_questions11_options1_title": "有信息但尚未向生物安全信息交换所提交",
  "Article20_questions11_options2_title": "有信息但只向生物安全信息交换所提交了一部分",
  "Article20_questions11_options3_title": "没有信息",
  "Article20_questions12_title": "关于针对拟直接作食物或饲料或加工之用的改性活生物体所采用的相关框架的声明（第11条第6款）",
  "Article20_questions12_options0_title": "有信息且已向生物安全信息交换所提交",
  "Article20_questions12_options1_title": "有信息但尚未向生物安全信息交换所提交",
  "Article20_questions12_options2_title": "有信息但只向生物安全信息交换所提交了一部分",
  "Article20_questions12_options3_title": "没有信息",
  "Article20_questions13_title": "关于改性活生物体有意越境转移的决定的审查和更改（第12条第1款）",
  "Article20_questions13_options0_title": "有信息且已向生物安全信息交换所提交",
  "Article20_questions13_options1_title": "有信息但尚未向生物安全信息交换所提交",
  "Article20_questions13_options2_title": "有信息但只向生物安全信息交换所提交了一部分",
  "Article20_questions13_options3_title": "没有信息",
  "Article20_questions14_title": "由各缔约方赋予豁免权的改性活生物体（第 13 条第 1 款）",
  "Article20_questions14_options0_title": "有信息且已向生物安全信息交换所提交",
  "Article20_questions14_options1_title": "有信息但尚未向生物安全信息交换所提交",
  "Article20_questions14_options2_title": "有信息但只向生物安全信息交换所提交了一部分",
  "Article20_questions14_options3_title": "没有信息",
  "Article20_questions15_title": "可能在通知进口缔约方的同时发生的有意越境转移案例（第 13 条第 1 款）",
  "Article20_questions15_options0_title": "有信息且已向生物安全信息交换所提交",
  "Article20_questions15_options1_title": "有信息但尚未向生物安全信息交换所提交",
  "Article20_questions15_options2_title": "有信息但只向生物安全信息交换所提交了一部分",
  "Article20_questions15_options3_title": "没有信息",
  "Article20_questions16_title": "在监管过程中产生的改性活生物体风险评估或环境审查以及有关产品相关信息的概述（第20条第3（c）款）",
  "Article20_questions16_options0_title": "有信息且已向生物安全信息交换所提交",
  "Article20_questions16_options1_title": "有信息但尚未向生物安全信息交换所提交",
  "Article20_questions16_options2_title": "有信息但只向生物安全信息交换所提交了一部分",
  "Article20_questions16_options3_title": "没有信息",
  "Article20_questions17_title": "贵国是否已建立相关机制以强化生物安全信息交换所国家联络点履行其行政职能的能力？",
  "Article20_questions18_title": "贵国是否已建立机制协调生物安全信息交换所国家联络点、《卡塔赫纳生物安全议定书》联络点以及国家主管部门向生物安全信息交换所提供信息的行动？",
  "Article20_questions19_title": "贵国是否在改性活生物体的决策过程中使用了向生物安全信息交换所提供的信息？",
  "Article20_questions19_options0_title": "是，经常",
  "Article20_questions19_options1_title": "是，有时",
  "Article20_questions20_title": "贵国是否在访问和使用生物安全信息交换所方面遇到过困难？",
  "Article20_questions21_title": "若贵国对第128个问题回答“是”，那么贵国是否已向生物安全信息交换所或秘书处报告此类问题？",
  "Article20_questions22_title": "贵国向生物安全信息交换所提供的信息是否完整和最新？",
  "Article20_questions23_title": "贵国可以在此提供有关贵国执行第20条的更多细节：",
  "Article21": "第21条",
  "Article21_title": "第21条 — 机密资料",
  "Article21_questions0_title": "贵国是否制定了相关程序保护从议定书收到的机密资料？",
  "Article21_questions1_title": "贵国是否允许通知人决定哪些资料列为机密？",
  "Article21_questions1_options0_title": "是，始终",
  "Article21_questions1_options1_title": "仅在某些情况下",
  "Article21_questions2_title": "贵国可以在此提供有关贵国执行第21条的更多细节：",
  "Article22": "第22条",
  "Article22_title": "第22条 - 能力建设",
  "Article22_questions0_title": "贵国是否在开发和/或加强生物安全人力资源和机构能力方面得到了外部支持，或受益于与其他缔约方的共同行动？",
  "Article22_questions1_title": "若您对第135个问题的回答为“是”，那么贵国是如何提供这些资源的？",
  "Article22_questions1_options0_title": "双边渠道",
  "Article22_questions1_options1_title": "区域渠道",
  "Article22_questions1_options2_title": "多边渠道",
  "Article22_questions2_title": "贵国是否向其他缔约方提供支持资助其开发和/或加强生物安全人力资源和机构能力？",
  "Article22_questions3_title": "若贵国对第137个问题回答“是”，贵国是如何提供这些资源的？",
  "Article22_questions3_options0_title": "双边渠道",
  "Article22_questions3_options1_title": "区域渠道",
  "Article22_questions3_options2_title": "多边渠道",
  "Article22_questions4_title": "贵国是否符合自全球环境基金（全环基金）接受资助的资格？",
  "Article22_questions5_title": "贵国是否启动过获得全环基金的生物技术能力建设资金的进程？",
  "Article22_questions6_title": "若贵国对第140个问题回答“是”，贵国对这一进程作如何的表述？",
  "Article22_questions6_options0_title": "很容易",
  "Article22_questions6_options1_title": "容易",
  "Article22_questions6_options2_title": "一般",
  "Article22_questions6_options3_title": "困难",
  "Article22_questions6_options4_title": "很困难",
  "Article22_questions7_title": "贵国是否曾从全环基金获得过用于建设生物安全能力的资金？",
  "Article22_questions7_options0_title": "试点性生物技术赋能活动",
  "Article22_questions7_options1_title": "制定国家生物安全框架",
  "Article22_questions7_options2_title": "执行国家生物安全框架",
  "Article22_questions7_options3_title": "有效参与生物安全信息交换所（第一期）的能力建设",
  "Article22_questions7_options4_title": "有效参与生物安全信息交换所（第二期）的能力建设",
  "Article22_questions7_options5_title": "有效参与生物安全信息交换所（第三期）的能力建设",
  "Article22_questions8_title": "在本报告所述期间内，贵国是否采取行动发展和/或加强生物安全人力资源和机构能力？",
  "Article22_questions9_title": "若贵国对第143个问题回答“是”，那么在下列哪些领域开展了此类行动？",
  "Article22_questions9_options0_title": "机构能力",
  "Article22_questions9_options1_title": "人力资源能力开发和培训",
  "Article22_questions9_options2_title": "风险评估及其他科学技术专业知识",
  "Article22_questions9_options3_title": "风险管理",
  "Article22_questions9_options4_title": "生物安全方面的公众认识、参与和教育",
  "Article22_questions9_options5_title": "信息交换和数据管理，包括参与生物安全信息交换所的活动",
  "Article22_questions9_options6_title": "在次区域、区域和国际层次上的科学、技术和机构合作",
  "Article22_questions9_options7_title": "技术转让",
  "Article22_questions9_options8_title": "改性活生物体的识别，包括其检测",
  "Article22_questions9_options9_title": "社会经济因素",
  "Article22_questions9_options10_title": "执行《议定书》第18.2条的单据要求",
  "Article22_questions9_options11_title": "机密资料的处理",
  "Article22_questions9_options12_title": "改性活生物体无意和/或非法越境转移的应对措施",
  "Article22_questions9_options13_title": "与改性活生物体相关的科学生物安全研究",
  "Article22_questions9_options14_title": "考虑对人类健康的风险",
  "Article22_questions10_title": "在本报告所述期间，贵国是否开展过一次能力建设需求评估？",
  "Article22_questions11_title": "贵国是否仍有能力建设方面的需求？",
  "Article22_questions11_options1_title": "是，很少",
  "Article22_questions12_title": "若贵国对第146个问题回答“是”，请标明下列哪些领域仍需开展能力建设。",
  "Article22_questions12_options0_title": "机构能力",
  "Article22_questions12_options1_title": "人力资源能力开发和培训",
  "Article22_questions12_options2_title": "风险评估及其他科学技术专业知识",
  "Article22_questions12_options3_title": "风险管理",
  "Article22_questions12_options4_title": "生物安全方面的公众认识、参与和教育",
  "Article22_questions12_options5_title": "信息交换和数据管理，包括参与生物安全信息交换所的活动",
  "Article22_questions12_options6_title": "在次区域、区域和国际层次上的科学、技术和机构合作",
  "Article22_questions12_options7_title": "技术转让",
  "Article22_questions12_options8_title": "改性活生物体的识别，包括其检测",
  "Article22_questions12_options9_title": "社会经济因素",
  "Article22_questions12_options10_title": "执行《议定书》第18.2条的单据要求",
  "Article22_questions12_options11_title": "机密资料的处理",
  "Article22_questions12_options12_title": "改性活生物体无意和/或非法越境转移的应对措施",
  "Article22_questions12_options13_title": "与改性活生物体相关的科学生物安全研究",
  "Article22_questions12_options14_title": "考虑对人类健康的风险",
  "Article22_questions13_title": "贵国是否已制定有能力建设战略或行动计划？",
  "Article22_questions14_title": "贵国是否向生物安全信息交换所专家名册提交了国家生物安全专家的详细资料？",
  "Article22_questions15_title": "贵国可以在此提供有关贵国执行第22条的更多细节：",
  "Article23": "第23条",
  "Article23_title": "第 23 条 – 公众意识和参与",
  "Article23_questions0_title": "贵国是否已就改性活生物体的安全转移、处理和使用制定了战略或立法，以提高和促进公众认识、教育和参与？",
  "Article23_questions0_options1_title": "是，某种程度上",
  "Article23_questions1_title": "贵国是否建立了生物安全网站？",
  "Article23_questions2_title": "贵国是否已建立了机制，以确保公众获得可以进口的改性活生物体的相关信息？",
  "Article23_questions2_options1_title": "是，在有限程度上",
  "Article23_questions3_title": "贵国是否已建立了机制，以在关于改性活生物体的决策过程中征求公众的意见？",
  "Article23_questions3_options1_title": "是，在有限程度上",
  "Article23_questions4_title": "贵国是否已建立了机制，以向公众通报有关改性活生物体的决策结果？",
  "Article23_questions4_options1_title": "是，在有限程度上",
  "Article23_questions5_title": "贵国是否采取过任何行动，以向公众公布获得生物安全信息交换所信息的方式？",
  "Article23_questions6_title": "在本报告所述期间内，贵国是否曾提高关于改性活生物体安全转移、处理和使用的公众认识、加强此方面的公众教育及参与？",
  "Article23_questions6_options1_title": "是，在有限程度上",
  "Article23_questions7_title": "若贵国对第157个问题回答“是”，那么贵国是否与其他缔约方和国际机构有过合作？",
  "Article23_questions8_title": "在本报告所述期间内，贵国有过多少次在关于改性活生物体的决策过程中征求公众的意见，并向公众公布此类决定的结果？",
  "Article23_questions8_options1_title": "不到5",
  "Article23_questions8_options2_title": "超过5",
  "Article23_questions9_title": "贵国可以在此提供有关贵国执行第23条的更多细节：",
  "Article24": "第24条",
  "Article24_title": "第 24 条 – 非缔约方",
  "Article24_questions0_title": "贵国是否已与非缔约方就改性活生物体的越境转移问题订立有任何双边、区域及多边协定？",
  "Article24_questions1_title": "贵国是否曾从某非缔约方进口改性活生物体？",
  "Article24_questions2_title": "贵国是否曾向某非缔约方出口改性活生物体？",
  "Article24_questions3_title": "若贵国对第162或第163个问题回答“是”，那么改性活生物体的越境转移是否符合《卡塔赫纳生物安全议定书》的目标？",
  "Article24_questions3_options0_title": "是，经常",
  "Article24_questions3_options1_title": "仅在某些情况下",
  "Article24_questions4_title": "若贵国对第162或第163个问题回答“是”，那么有关此类越境转移的信息是否已向生物安全信息交换所提交？",
  "Article24_questions4_options0_title": "是，经常",
  "Article24_questions4_options1_title": "仅在某些情况下",
  "Article24_questions5_title": "若贵国并非《卡塔赫纳议定书》的缔约方，那么贵国是否曾向生物安全信息交换所贡献有关改性活生物体在其国家辖区内释放或转移进出的信息？",
  "Article24_questions5_options0_title": "是，经常",
  "Article24_questions5_options1_title": "仅在某些情况下",
  "Article24_questions6_title": "贵国可以在此提供有关贵国执行第 24 条的更多细节：",
  "Article25": "第25条",
  "Article25_title": "第 25 条 – 非法越境转移",
  "Article25_questions0_title": "贵国是否已在国内采取适当措施，以防止和/或惩处违反其执行本《议定书》的国内措施而进行的改性活生物体越境转移？",
  "Article25_questions1_title": "贵国是否制定了战略监测改性活生物体的非法越境转移？",
  "Article25_questions2_title": "在本报告所述期间内，贵国曾几次获得有关某种改性活生物体在贵国管辖范围内非法越境转移的事件信息？",
  "Article25_questions2_options0_title": "从来没有",
  "Article25_questions2_options1_title": "不到5",
  "Article25_questions2_options2_title": "不到 10 人",
  "Article25_questions2_options3_title": "超过10",
  "Article25_questions3_title": "贵国是否曾告知生物安全信息交换所及其他有关缔约方？",
  "Article25_questions3_options1_title": "仅在某些情况下",
  "Article25_questions3_options2_title": "仅告知过其他有关缔约方",
  "Article25_questions3_options3_title": "仅告知过生物安全信息交换所",
  "Article25_questions4_title": "贵国是否已确定了改性活生物体的来源？",
  "Article25_questions4_options1_title": "是，在某些情况下",
  "Article25_questions5_title": "贵国是否已确定了改性活生物体的性质？",
  "Article25_questions5_options1_title": "是，在某些情况下",
  "Article25_questions6_title": "贵国是否已确定了非法越境转移的情形？",
  "Article25_questions6_options1_title": "是，在某些情况下",
  "Article25_questions7_title": "贵国可以在此提供有关贵国执行第25条的更多细节：",
  "Article26": "第26条",
  "Article26_title": "第26条 - 社会-经济因素",
  "Article26_questions0_title": "若贵国已就进口事宜做出决定，该决定是否虑及改性活生物体对生物多样性的保护和可持续利用造成的社会经济影响？",
  "Article26_questions0_options1_title": "仅在某些情况下",
  "Article26_questions0_options3_title": "不适用",
  "Article26_questions1_title": "贵国是否曾就改性活生物体的任何社会经济影响与其他缔约方开展过合作研究和信息交流？",
  "Article26_questions1_options1_title": "是，在有限程度上",
  "Article26_questions2_title": "贵国可以在此提供有关贵国执行第26条的更多细节：",
  "Article27": "第27条",
  "Article27_title": "第 27 条 – 赔偿责任和补救",
  "Article27_questions0_title": "贵国是否已签署《赔偿责任和补救问题名古屋－吉隆坡补充议定书》？",
  "Article27_questions1_title": "贵国是否开始了批准、接受或核准《名古屋－吉隆坡补充议定书》的步骤？",
  "Article27_questions2_title": "贵国可以在此提供有关贵国为执行《名古屋－吉隆坡补充议定书》而开展的任何活动的更多细节：",
  "Article33": "第33条",
  "Article33_title": "第 33 条 – 监测与汇报",
  "Article33_questions0_title": "贵国此前是否已提交过国家报告（临时和第一次国家报告）？",
  "Article33_questions0_options1_title": "是，仅提交过临时报告",
  "Article33_questions0_options2_title": "是，仅提交过第一次报告",
  "Article33_questions1_title": "若贵国此前并未提交过报告，请说明阻碍提交的主要困难",
  "Article33_questions1_options0_title": "缺乏收集必要信息的财政资源",
  "Article33_questions1_options1_title": "缺乏国家一级的相关信息",
  "Article33_questions1_options2_title": "难以汇编各部门信息",
  "Article33_questions1_options3_title": "没有义务提交（如，当时本国并非缔约方）",
  "AdditionalInformation": "其他信息",
  "AdditionalInformation_title": "其他信息",
  "AdditionalInformation_questions0_title": "请在此处提供与《卡塔赫纳议定书》和《补充议定书》执行情况有关的任何其他信息，包括遇到的任何障碍或阻碍。",
  "Comments": "评论",
  "Comments_title": "对报告格式的评论",
  "Comments_questions0_title": "请使用此空间提供有关贵国在填写本报告过程中遇到困难的任何其他信息。",
  "Survey": "调查",
  "Survey_title": "有关战略计划（2014年）指标的调查",
  "Survey_questions0_title": "贵国国家生物多样性框架哪一年投入运作？",
  "Survey_questions0_options0_title": "2001 年或更早",
  "Survey_questions0_options1_title": "2002",
  "Survey_questions0_options2_title": "2003",
  "Survey_questions0_options3_title": "2004",
  "Survey_questions0_options4_title": "2005",
  "Survey_questions0_options5_title": "2006",
  "Survey_questions0_options6_title": "2007",
  "Survey_questions0_options7_title": "2008",
  "Survey_questions0_options8_title": "2009",
  "Survey_questions0_options9_title": "2010",
  "Survey_questions0_options10_title": "2011",
  "Survey_questions0_options11_title": "2012",
  "Survey_questions0_options12_title": "2013",
  "Survey_questions0_options13_title": "2014",
  "Survey_questions1_title": "贵国每年提供了多少个生物安全短期培训项目和/或学术课程？",
  "Survey_questions1_options1_title": "每年少于 1",
  "Survey_questions1_options2_title": "每年 1 或以上",
  "Survey_questions1_options3_title": "每年 5 个或 5 个以上",
  "Survey_questions1_options4_title": "每年 10 个或 10 个以上",
  "Survey_questions2_title": "贵国是否已拥有功能性的国家机制来协调生物安全方面的能力建设举措？",
  "Survey_questions3_title": "除经常国家预算分配以外，贵国在过去四年内调动了多少额外资金（换算成美元）以支持实施《生物安全议定书》？",
  "Survey_questions3_options0_title": "不到 5,000美元",
  "Survey_questions3_options1_title": "5,000 美元或以上",
  "Survey_questions3_options2_title": "50,000 美元或以上",
  "Survey_questions3_options3_title": "100,000 美元或以上",
  "Survey_questions3_options4_title": "500,000美元或以上",
  "Survey_questions3_options5_title": "1,000,000 美元或以上",
  "Survey_questions3_options6_title": "5,000,000 美元或以上",
  "Survey_questions4_title": "贵国是否拥有可预见和可靠的资金来进行能力建设以有效实施《议定书》？",
  "Survey_questions5_title": "贵国曾与其他缔约方/非缔约方建立了多少与改性活生物体相关的双边/多边合作安排？",
  "Survey_questions5_options1_title": "1 或以上",
  "Survey_questions5_options2_title": "3 或以上",
  "Survey_questions5_options3_title": "5 或以上",
  "Survey_questions5_options4_title": "10人或超过10人",
  "Survey_questions6_title": "贵国在开展风险评估及/或风险管理时是否采用或使用过任何指导性文件？\r\n风险评估",
  "Survey_questions7_title": "贵国在开展风险评估及/或风险管理时是否采用或使用过任何指导性文件？\r\n风险管理",
  "Survey_questions8_title": "贵国在评估通知人提交的风险评估报告时是否采用或使用过任何指导性文件？",
  "Survey_questions9_title": "贵国是否已采用任何与其他国家相同的风险评估方法？",
  "Survey_questions10_title": "贵国是否开展过改性活生物体风险评估？",
  "Survey_questions11_title": "贵国是否有能力鉴别、评估和/或监测可能对生物多样性保护和可持续利用产生不利影响的改性活生物体或具体特性，考虑对人类健康的风险？\r\n识别",
  "Survey_questions12_title": "贵国是否有能力鉴别、评估和/或监测可能对生物多样性保护和可持续利用产生不利影响的改性活生物体或具体特性，考虑对人类健康的风险？\r\n评估",
  "Survey_questions13_title": "贵国是否有能力鉴别、评估和/或监测可能对生物多样性保护和可持续利用产生不利影响的改性活生物体或具体特性，考虑对人类健康的风险？\r\n监测",
  "Survey_questions14_title": "贵国是否具有可用的指南来确保改性活生物体的安全处理、运输和包装？",
  "Survey_questions15_title": "贵国是否有任何具体措施或要求，以帮助在改性活生物体决策中考虑社会经济因素？",
  "Survey_questions16_title": "贵国使用了多少种经过同行评审的出版材料，以供详细说明或确定与社会经济因素相关的国家行动？",
  "Survey_questions16_options1_title": "1 或以上",
  "Survey_questions16_options2_title": "5 或以上",
  "Survey_questions16_options3_title": "10人或超过10人",
  "Survey_questions16_options4_title": "50 个或 50 个以上",
  "Survey_questions17_title": "对于在改性活生物体决策中考虑社会经济因素，贵国有什么经验（如有的话）？",
  "Survey_questions18_title": "贵国是否有能力采取适当措施，以防改性活生物体意外释放？",
  "Survey_questions19_title": "贵国有多少人曾受过改性活生物体风险评估、监测、管理和控制的培训？\r\n风险评估",
  "Survey_questions19_options1_title": "1 或以上",
  "Survey_questions19_options2_title": "10 个或 10 个以上",
  "Survey_questions19_options3_title": "50 个或 50 个以上",
  "Survey_questions19_options4_title": "100 个或 100 个以上",
  "Survey_questions20_title": "贵国有多少人曾受过改性活生物体风险评估、监测、管理和控制的培训？\r\n监测",
  "Survey_questions20_options1_title": "1 或以上",
  "Survey_questions20_options2_title": "10 个或 10 个以上",
  "Survey_questions20_options3_title": "50 个或 50 个以上",
  "Survey_questions20_options4_title": "100 个或 100 个以上",
  "Survey_questions21_title": "贵国有多少人曾受过改性活生物体风险评估、监测、管理和控制的培训？\r\n管理/控制",
  "Survey_questions21_options1_title": "1 或以上",
  "Survey_questions21_options2_title": "10 个或 10 个以上",
  "Survey_questions21_options3_title": "50 个或 50 个以上",
  "Survey_questions21_options4_title": "100 个或 100 个以上",
  "Survey_questions22_title": "贵国是否有对改性活生物体进行监测或管理的基础设施（例如，实验室设施）？",
  "Survey_questions23_title": "贵国是否在改性活生物体风险评估和风险管理培训中使用了培训材料和/或技术指导？",
  "Survey_questions24_title": "所用改性活生物体风险评估和风险管理的培训材料及培训技术指南是否充分及有效？\r\n充分",
  "Survey_questions25_title": "所用改性活生物体风险评估和风险管理的培训材料及培训技术指南是否充分及有效？\r\n有效",
  "Survey_questions26_title": "贵国有多少名海关人员接受过识别改性活生物体的培训？",
  "Survey_questions26_options1_title": "1 或以上",
  "Survey_questions26_options2_title": "10 个或 10 个以上",
  "Survey_questions26_options3_title": "50 个或 50 个以上",
  "Survey_questions26_options4_title": "100 个或 100 个以上",
  "Survey_questions27_title": "贵国有多少名实验室人员接受过检测改性活生物体的培训？",
  "Survey_questions27_options1_title": "1 或以上",
  "Survey_questions27_options2_title": "10 个或 10 个以上",
  "Survey_questions27_options3_title": "50 个或 50 个以上",
  "Survey_questions27_options4_title": "100 个或 100 个以上",
  "Survey_questions28_title": "贵国是否拥有用于改性活生物体检测之实验室设施的可靠使用权？",
  "Survey_questions29_title": "贵国有多少个实验室具有检测改性活生物体的资格？",
  "Survey_questions29_options1_title": "1 或以上",
  "Survey_questions29_options2_title": "5 或以上",
  "Survey_questions29_options3_title": "10人或超过10人",
  "Survey_questions29_options4_title": "50 个或 50 个以上",
  "Survey_questions30_title": "在上个问题中提到的持有证书的实验室中，有多少在运作中？",
  "Survey_questions30_options1_title": "1 或以上",
  "Survey_questions30_options2_title": "5 或以上",
  "Survey_questions30_options3_title": "10人或超过10人",
  "Survey_questions30_options4_title": "50 个或 50 个以上",
  "Survey_questions31_title": "贵国是否曾收到任何财务和/或技术援助，以开展有关改性活生物体的赔偿责任和补救方面的能力建设？",
  "Survey_questions32_title": "贵国是否有规定了因改性活生物体而损害生物多样性的应对措施的行政或法律文书？",
  "Survey_questions33_title": "贵国是否已告知公众现有的公众参与关于改性活生物体的决策过程的形式？",
  "Survey_questions34_title": "若您对上一问题的回答为“是”，那么请指出向公众进行通报所用的方式：",
  "Survey_questions34_options0_title": "国家网站",
  "Survey_questions34_options1_title": "报纸",
  "Survey_questions34_options2_title": "论坛",
  "Survey_questions34_options3_title": "通讯名单",
  "Survey_questions34_options4_title": "公众听证会",
  "Survey_questions35_title": "若贵国在上方问题中指出了多种公众参与形式，哪一种是最常用的？",
  "Survey_questions35_options0_title": "国家网站",
  "Survey_questions35_options1_title": "报纸",
  "Survey_questions35_options2_title": "论坛",
  "Survey_questions35_options3_title": "通讯名单",
  "Survey_questions35_options4_title": "公众听证会",
  "Survey_questions36_title": "贵国有多少个学术机构正在提供生物安全教育和培训课程和方案？",
  "Survey_questions36_options1_title": "1 或以上",
  "Survey_questions36_options2_title": "3 或以上",
  "Survey_questions36_options3_title": "5 或以上",
  "Survey_questions36_options4_title": "10人或超过10人",
  "Survey_questions37_title": "贵国有多少个可用的生物安全培训资料和/或在线模块？",
  "Survey_questions37_options1_title": "1 或以上",
  "Survey_questions37_options2_title": "5 或以上",
  "Survey_questions37_options3_title": "10人或超过10人",
  "Survey_questions37_options4_title": "25 个或 25 个以上",
  "Survey_questions37_options5_title": "100 个或 100 个以上",
  "Survey_questions38_title": "贵国是否有监测和/或实施制度？\r\n监测系统",
  "Survey_questions39_title": "贵国是否有监测和/或实施制度？\r\n实施制度",
  "Survey_questions40_title": "请指出在过去的2年内所组织的与生物安全相关的区域、国家和国际活动的数量（例如：研讨会、研习会、新闻发布会、教育活动等）。",
  "Survey_questions40_options1_title": "1 或以上",
  "Survey_questions40_options2_title": "5 或以上",
  "Survey_questions40_options3_title": "10人或超过10人",
  "Survey_questions40_options4_title": "25 个或 25 个以上",
  "Survey_questions41_title": "请指出去年在贵国发布的生物安全相关的出版物的数量。",
  "Survey_questions41_options1_title": "1 或以上",
  "Survey_questions41_options2_title": "10 个或 10 个以上",
  "Survey_questions41_options3_title": "50 个或 50 个以上",
  "Survey_questions41_options4_title": "100 个或 100 个以上",
  "Survey_questions42_title": "若贵国发布了生物安全相关的出版物（见上个问题），那么请指出首选的形式。",
  "Survey_questions42_options0_title": "国家网站",
  "Survey_questions42_options1_title": "国家图书馆",
  "Survey_questions42_options2_title": "生物安全信息交换所中央门户",
  "Survey_questions43_title": "贵国政府在过去 4 年中建立了多少次关于《卡塔赫纳议定书》及其他公约和进程的合作方案（包括联合活动）？",
  "Survey_questions43_options1_title": "1 或以上",
  "Survey_questions43_options2_title": "5 或以上",
  "Survey_questions43_options3_title": "10人或超过10人",
  "Survey_questions43_options4_title": "25 个或 25 个以上",
  "Survey_questions44_title": "贵国是否有生物安全意识和外联方案？",
  "Survey_questions45_title": "若贵国对上一个问题回答“是”，那么请指出哪个实体负责开展项目和/或服务，以及项目进行的级别。",
  "Survey_questions46_title": "贵国是否设计和/或实施了生物安全推广/沟通策略？",
  "Survey_questions47_title": "请指出提供给公众的关于生物安全的教育材料的数量。",
  "Survey_questions47_options1_title": "1 或以上",
  "Survey_questions47_options2_title": "5 或以上",
  "Survey_questions47_options3_title": "10人或超过10人",
  "Survey_questions47_options4_title": "25 个或 25 个以上",
  "Survey_questions47_options5_title": "100 个或 100 个以上",
  "#meta": {
    "hashedOn": "2024-05-05T18:52:50.172Z",
    "algorithm": "md5",
    "branch": "2024.13.3",
    "hashes": {
      "Yes": "93cba07454f06a4a960172bbd6e2a435",
      "No": "bafd7322c6e97d25b6299b5d6fe8920b",
      "Other": "6311ae17c1ee52b36e68aaf4ad066387",
      "None": "6adf97f83acf6453d4a6a4b1070f3754",
      "General": "0db377921f4ce762c62526131097968f",
      "General_title": "36c00f085907906a0f60ca66c682a8a9",
      "General_questions0_title": "451c9de3ee9c765ef64fbf76d89f58cb",
      "General_questions1_title": "1ebd890dcff73374d9aca205d304680a",
      "General_questions2_title": "28ab637c6d1fb28f26daf544a5d78818",
      "Article2": "abb3befe9c66f3086de861fdd1db6084",
      "Article2_title": "5cc63abd8d0d57c8ab93f1d5ec880d12",
      "Article2_questions0_title": "882626dac5351150415af98a042dfb4b",
      "Article2_questions0_options0_title": "245406305ce50f903b9c400ab859ec91",
      "Article2_questions0_options1_title": "f9c7069544a7d0717cda4f495f1e9c79",
      "Article2_questions0_options2_title": "ad3027e19d25a83b801a374b4c2959a4",
      "Article2_questions0_options3_title": "82779847f72aa4aa33ec1b5429654072",
      "Article2_questions0_options4_title": "7b55ce25b4b47c8b73a370f25cbed22d",
      "Article2_questions1_title": "15f6d733f8977084459f0ca197cdfaa4",
      "Article2_questions1_options0_title": "33b4cc297f825c1637f23cfc9e007db3",
      "Article2_questions1_options1_title": "a225954a3e6adbd72ba3be6665970cfe",
      "Article2_questions1_options2_title": "2df89da64f9d701cddf425dd2688b9c2",
      "Article2_questions1_options3_title": "0c71dc82baa716a47efb8ae6d7a8dcd4",
      "Article2_questions1_options4_title": "82a2681f3fb95e3d671ad06400742086",
      "Article2_questions2_title": "86359ca2d4e9b10902e503aa79ea66ab",
      "Article2_questions3_title": "8949b5c62610edefc14f4929fb48ad0c",
      "Article2_questions4_title": "14b7e00ce3e0cf7a84706b95b0572246",
      "Article2_questions4_options0_title": "06c2cea18679d64399783748fa367bdd",
      "Article2_questions4_options1_title": "d5f723e2c82bcdac380b7b027e598752",
      "Article2_questions4_options2_title": "b7fd007b0d920849a5b309d3a86348b1",
      "Article2_questions4_options3_title": "97d085044b0cbe405129de4b7b0ca382",
      "Article2_questions5_title": "c369aa40ed5e69b880e506cd9e843435",
      "Article2_questions5_options1_title": "b9f06d0c15ebfec15d2939dd5f7d3d3c",
      "Article2_questions6_title": "3fc6c65532deade1c9a1ab53dd267ffd",
      "Article5": "1eb8e54928622688fd7ad6e5471a4082",
      "Article5_title": "4e317eb85497776ac873b8918e333004",
      "Article5_questions0_title": "f0f3c2c1c3f4481d83d7fc298024ecb3",
      "Article5_questions0_options1_title": "cd5db912023c67c1fdf38fb79fbcfa56",
      "Article5_questions1_title": "53844b28af1d34a398fa93081de8600d",
      "Article5_questions1_options1_title": "b9f06d0c15ebfec15d2939dd5f7d3d3c",
      "Article5_questions2_title": "27b265785c2261f7266befddc00981c6",
      "Article6": "754a26602ebad027946b86bada875fb1",
      "Article6_title": "0265fad5c0ffbf88eef58f278347f76a",
      "Article6_questions0_title": "2783db95fee418ab0a3147fdd926844a",
      "Article6_questions1_title": "63b0f4565ecd96bc3276e55ab17b1f93",
      "Article6_questions2_title": "82e6b59ca47ddf2f6e84d4cbd975f0b6",
      "Article6_questions2_options1_title": "b9f06d0c15ebfec15d2939dd5f7d3d3c",
      "Article6_questions3_title": "91077f09fc82ded3c3a5fe7799536c27",
      "Articles7-10": "7c43310cd1f1c786a6735f0638c0cb5a",
      "Articles7_10_title": "51d1062790cad29915715f679e6affc2",
      "Articles7_10_questions0_title": "6fcc17b46844523fd03e7c0c7f422fd3",
      "Articles7_10_questions1_title": "5563458214fb97a4e407679c075065a3",
      "Articles7_10_questions2_title": "ea4d7d3e6cc25ec5cf941d37c6b62ada",
      "Articles7_10_questions3_title": "c2fea83afc1131266767e2ef38d0c01d",
      "Articles7_10_questions4_title": "92a4fd1173a9e79d50e711c91401485e",
      "Articles7_10_questions5_title": "2c06a31d779519e8fd547bb81d765279",
      "Articles7_10_questions5_options1_title": "cd5db912023c67c1fdf38fb79fbcfa56",
      "Articles7_10_questions6_title": "c24efc7b8335590ddb6d3bb6d825e6cd",
      "Articles7_10_questions7_title": "a2ca3cb8f0b9ef9ebd86295f8568b550",
      "Articles7_10_questions8_title": "5764292dc428fd40ff1e0719d602588f",
      "Articles7_10_questions9_title": "f7ea36047994e8d58d2f6781fef5be97",
      "Articles7_10_questions10_title": "9a33aaa910436f20ee3bd8c5ff2428b2",
      "Articles7_10_questions10_options1_title": "d5f723e2c82bcdac380b7b027e598752",
      "Articles7_10_questions10_options2_title": "b7fd007b0d920849a5b309d3a86348b1",
      "Articles7_10_questions10_options3_title": "97d085044b0cbe405129de4b7b0ca382",
      "Articles7_10_questions11_title": "0fe3d9e5ad701f5dd46cbea5f1dffc95",
      "Articles7_10_questions11_options1_title": "d5f723e2c82bcdac380b7b027e598752",
      "Articles7_10_questions11_options2_title": "b7fd007b0d920849a5b309d3a86348b1",
      "Articles7_10_questions11_options3_title": "97d085044b0cbe405129de4b7b0ca382",
      "Articles7_10_questions12_title": "0753f4fada133ce949246d9325dbc9b5",
      "Articles7_10_questions12_options1_title": "d5f723e2c82bcdac380b7b027e598752",
      "Articles7_10_questions12_options2_title": "b7fd007b0d920849a5b309d3a86348b1",
      "Articles7_10_questions12_options3_title": "97d085044b0cbe405129de4b7b0ca382",
      "Articles7_10_questions13_title": "5829cc162f1a4b435e30ff4c4a79965c",
      "Articles7_10_questions13_options1_title": "d5f723e2c82bcdac380b7b027e598752",
      "Articles7_10_questions13_options2_title": "b7fd007b0d920849a5b309d3a86348b1",
      "Articles7_10_questions13_options3_title": "97d085044b0cbe405129de4b7b0ca382",
      "Articles7_10_questions14_title": "1016dc070bf4ed07f121ecdc39023753",
      "Articles7_10_questions14_options0_title": "a05c8bc04b67d979613653210e895247",
      "Articles7_10_questions14_options1_title": "701ae6a85673e4f24f000a47e178b8f2",
      "Articles7_10_questions15_title": "8ba48d5965847539c3056f95f472d67d",
      "Articles7_10_questions15_options0_title": "a05c8bc04b67d979613653210e895247",
      "Articles7_10_questions15_options1_title": "701ae6a85673e4f24f000a47e178b8f2",
      "Articles7_10_questions16_title": "945ffeeee2a70f522d7858b937a610c2",
      "Articles7_10_questions16_options0_title": "a05c8bc04b67d979613653210e895247",
      "Articles7_10_questions16_options1_title": "701ae6a85673e4f24f000a47e178b8f2",
      "Articles7_10_questions17_title": "2db59260e4b4efb187eb431e033c6fce",
      "Articles7_10_questions17_options0_title": "a05c8bc04b67d979613653210e895247",
      "Articles7_10_questions17_options1_title": "701ae6a85673e4f24f000a47e178b8f2",
      "Articles7_10_questions17_options2_title": "0bd8f89329ea53b2100443b82707b549",
      "Articles7_10_questions17_options3_title": "657d992c8e7ea28fbd84caa29c2041f6",
      "Articles7_10_questions18_title": "29e9530cc593f9fe362a0eaf083564b2",
      "Articles7_10_questions18_options0_title": "a05c8bc04b67d979613653210e895247",
      "Articles7_10_questions18_options1_title": "701ae6a85673e4f24f000a47e178b8f2",
      "Articles7_10_questions19_title": "c3982c41772a42aa1a033999243164e6",
      "Articles7_10_questions19_options0_title": "113010039896a11b08833fc42c96260b",
      "Articles7_10_questions19_options1_title": "60feb07126439578f5d6e8c592db6382",
      "Articles7_10_questions19_options2_title": "5862390854284a25a34da1dae75b9e84",
      "Articles7_10_questions19_options3_title": "24a9a1ed3f9957c11a97fb02cc873b79",
      "Articles7_10_questions19_options4_title": "7b1d2d6f93dee0ff6faa8b7fffdbed90",
      "Articles7_10_questions20_title": "1decbf1fa89a109f576fc8f68a63de10",
      "Articles7_10_questions20_options0_title": "a05c8bc04b67d979613653210e895247",
      "Articles7_10_questions20_options1_title": "701ae6a85673e4f24f000a47e178b8f2",
      "Articles7_10_questions20_options2_title": "0bd8f89329ea53b2100443b82707b549",
      "Articles7_10_questions20_options3_title": "657d992c8e7ea28fbd84caa29c2041f6",
      "Articles7_10_questions21_title": "9d5dcc8bf9fb98fe4990d88bc4daa989",
      "Article11": "9221bd7aa2dae24ed9b9362633b5455d",
      "Article11_title": "ec4ec25fcf214cc329d7b2e8304c89c3",
      "Article11_questions0_title": "86a8ddd88d6410c8ea298df07f690b1a",
      "Article11_questions1_title": "f0aae02d60c389778f7b7b4951b30f15",
      "Article11_questions2_title": "bcdc688855387419f4891a7bd77f5867",
      "Article11_questions3_title": "3d9c1a74c7f9f1b4cad70aa40ee60020",
      "Article11_questions4_title": "10e774545643271951130eeb17464953",
      "Article11_questions5_title": "122080f2e105ea3c283af6a280870154",
      "Article11_questions6_title": "526cec3d869ca8a1252d31ec15aff69e",
      "Article11_questions7_title": "0bf246b6d167e66e61cdbda87ea593cb",
      "Article11_questions7_options1_title": "d5f723e2c82bcdac380b7b027e598752",
      "Article11_questions7_options2_title": "b7fd007b0d920849a5b309d3a86348b1",
      "Article11_questions7_options3_title": "97d085044b0cbe405129de4b7b0ca382",
      "Article11_questions8_title": "ab2630fd74dc5e4b6a040c6a353d69d9",
      "Article11_questions8_options1_title": "d5f723e2c82bcdac380b7b027e598752",
      "Article11_questions8_options2_title": "b7fd007b0d920849a5b309d3a86348b1",
      "Article11_questions8_options3_title": "97d085044b0cbe405129de4b7b0ca382",
      "Article11_questions9_title": "9ad8616e29c0937a5d1170c4f354a144",
      "Article11_questions9_options1_title": "d5f723e2c82bcdac380b7b027e598752",
      "Article11_questions9_options2_title": "b7fd007b0d920849a5b309d3a86348b1",
      "Article11_questions9_options3_title": "97d085044b0cbe405129de4b7b0ca382",
      "Article11_questions10_title": "074a6750b05005e374c88ac542aae46f",
      "Article11_questions10_options0_title": "a05c8bc04b67d979613653210e895247",
      "Article11_questions10_options1_title": "701ae6a85673e4f24f000a47e178b8f2",
      "Article11_questions11_title": "d11a9175866b9ce41b6599549010b23d",
      "Article11_questions11_options0_title": "a05c8bc04b67d979613653210e895247",
      "Article11_questions11_options1_title": "701ae6a85673e4f24f000a47e178b8f2",
      "Article11_questions11_options2_title": "6aa2ff094dc05eb4b0ade167579cd98b",
      "Article11_questions12_title": "5b48c88e378b018ac9f2d6b1b246ee9d",
      "Article12": "98e72a7eed43b39900b2f4b0bbb42a11",
      "Article12_title": "90d6aa541c8cd667a51cbc00a8852f51",
      "Article12_questions0_title": "67ad6ba15ce8a85633becbd3f0d92a50",
      "Article12_questions1_title": "57827b6c65b63fface14a473d5c30c74",
      "Article12_questions2_title": "965ff7f4bf729876b47fafca81ca1b2b",
      "Article12_questions2_options0_title": "9f5bc1a1ff1649e7adfcce6b3da3e8a0",
      "Article12_questions2_options1_title": "962c3e4e76be54cdf809cbda84259d1c",
      "Article12_questions3_title": "2302eefeaf41cb069e11f1bd06f89a6d",
      "Article12_questions3_options1_title": "d5f723e2c82bcdac380b7b027e598752",
      "Article12_questions3_options2_title": "7e66620b31cefb033e4ca560d32be5e1",
      "Article12_questions4_title": "87dcf6b2a2144f24b55c7f5fc4c049a2",
      "Article12_questions4_options0_title": "a05c8bc04b67d979613653210e895247",
      "Article12_questions4_options1_title": "701ae6a85673e4f24f000a47e178b8f2",
      "Article12_questions4_options2_title": "0bd8f89329ea53b2100443b82707b549",
      "Article12_questions4_options3_title": "657d992c8e7ea28fbd84caa29c2041f6",
      "Article12_questions5_title": "7c68b065d0d2704f25ddc1bd0b57420a",
      "Article12_questions5_options0_title": "a05c8bc04b67d979613653210e895247",
      "Article12_questions5_options1_title": "701ae6a85673e4f24f000a47e178b8f2",
      "Article12_questions5_options2_title": "92740570cf1965e0964a956555ba6fd6",
      "Article12_questions6_title": "ea37ed1a1fcff30b4ca020acdba4772b",
      "Article12_questions6_options0_title": "a05c8bc04b67d979613653210e895247",
      "Article12_questions6_options1_title": "701ae6a85673e4f24f000a47e178b8f2",
      "Article12_questions6_options2_title": "0bd8f89329ea53b2100443b82707b549",
      "Article12_questions6_options3_title": "657d992c8e7ea28fbd84caa29c2041f6",
      "Article12_questions7_title": "326633927362aa5e242586a5a749b468",
      "Article13": "3198a58a4e418dfab762b80390db2267",
      "Article13_title": "4ff03ba84e8db6cd2ad40d23e7425830",
      "Article13_questions0_title": "0b0fbe4bfcd5242a0a2256a393b03128",
      "Article13_questions1_title": "c3b5e29e2daee052f16b8073a3e9bd7a",
      "Article13_questions2_title": "7bbe9191abf9ad1d91a4f70222ffd1cb",
      "Article13_questions2_options0_title": "a05c8bc04b67d979613653210e895247",
      "Article13_questions2_options1_title": "701ae6a85673e4f24f000a47e178b8f2",
      "Article13_questions3_title": "69e45d2ca7a05ba441481b59a576a4b0",
      "Article13_questions3_options1_title": "d5f723e2c82bcdac380b7b027e598752",
      "Article13_questions3_options2_title": "7e66620b31cefb033e4ca560d32be5e1",
      "Article13_questions4_title": "6905d81a2da0330c07b6514eafc25594",
      "Article14": "e2989d5a22fe307db647b1991b3bd732",
      "Article14_title": "194c1a3543e8d8399fb4b663eded5f0f",
      "Article14_questions0_title": "6969a06d6ae9e2367f1b29c691481aa7",
      "Article14_questions1_title": "653727cc519ee0851ec750962a986d41",
      "Article14_questions1_options0_title": "a05c8bc04b67d979613653210e895247",
      "Article14_questions1_options1_title": "701ae6a85673e4f24f000a47e178b8f2",
      "Article14_questions2_title": "fb6c60bc56e133bbac25bf1103df5a4e",
      "Article14_questions3_title": "a1c3defcb7ceeda2d7c43609b9d390c1",
      "Article15": "cee0476340c53fd974712595994bee6c",
      "Article15_title": "ee37b1ef9f31154aa9b64ad2bc05a6c3",
      "Article15_questions0_title": "80bdc4b55490796855000dd6a2e86b37",
      "Article15_questions1_title": "3d19d096255dac9e19f4b85bd8bf26e2",
      "Article15_questions2_title": "0a2b473df1aa8344ed404244f47e5449",
      "Article15_questions3_title": "642afaf04316625bbf616c11848b127a",
      "Article15_questions4_title": "54467d04fb4a0c405647082a1f8a4fa4",
      "Article15_questions5_title": "173e05d3c9f8243fd9f2cf9ff40b295f",
      "Article15_questions6_title": "c09587d1732ec48f46abc24275848c06",
      "Article15_questions7_title": "afba9fbf75051e01a1348c8e37b378db",
      "Article15_questions7_options0_title": "a05c8bc04b67d979613653210e895247",
      "Article15_questions7_options1_title": "701ae6a85673e4f24f000a47e178b8f2",
      "Article15_questions8_title": "2ef32f2f5394e7095279be3b91166c65",
      "Article15_questions8_options0_title": "a05c8bc04b67d979613653210e895247",
      "Article15_questions8_options1_title": "701ae6a85673e4f24f000a47e178b8f2",
      "Article15_questions9_title": "0715f88502d31f4e72b162a9ce5f8a1a",
      "Article15_questions9_options1_title": "d5f723e2c82bcdac380b7b027e598752",
      "Article15_questions9_options2_title": "b7fd007b0d920849a5b309d3a86348b1",
      "Article15_questions9_options3_title": "97d085044b0cbe405129de4b7b0ca382",
      "Article15_questions10_title": "bab203939dbe3dcdb0be5a629cbda605",
      "Article15_questions10_options0_title": "a05c8bc04b67d979613653210e895247",
      "Article15_questions10_options1_title": "701ae6a85673e4f24f000a47e178b8f2",
      "Article15_questions11_title": "8919931d29abf261063154531ff6bead",
      "Article15_questions11_options0_title": "a05c8bc04b67d979613653210e895247",
      "Article15_questions11_options1_title": "701ae6a85673e4f24f000a47e178b8f2",
      "Article15_questions12_title": "dbff77ac398cbf4aa279de2d7ce49eaa",
      "Article16": "63556f77fa914bbdba40a3ec88eeb377",
      "Article16_title": "8f42188ca5bfb0c6740896df820b1fe3",
      "Article16_questions0_title": "7f68bccfe7cc83cf1a4019f24d6edf14",
      "Article16_questions0_options1_title": "cd5db912023c67c1fdf38fb79fbcfa56",
      "Article16_questions1_title": "1f941e74d4c09127694bd232848f6d89",
      "Article16_questions1_options1_title": "cd5db912023c67c1fdf38fb79fbcfa56",
      "Article16_questions2_title": "4cb10ddf99706084ce43dc2cb0fff23a",
      "Article16_questions2_options1_title": "cd5db912023c67c1fdf38fb79fbcfa56",
      "Article16_questions3_title": "9b4e1381bb8548d8eaa4f54100b94839",
      "Article16_questions4_title": "544947f19eae0bb37ff4a7bd0490d997",
      "Article16_questions5_title": "4bbc5096ee605e4d251a8230896961e9",
      "Article16_questions6_title": "2f4b8e2c2010f2fdec0b31a4d8dc9e80",
      "Article17": "c3167df10572c89efa0c1a5341625f87",
      "Article17_title": "8aa12fbc027c718191ed718baa812dc5",
      "Article17_questions0_title": "88715d00bab8bd43b9556c7ecbe8543b",
      "Article17_questions1_title": "3361cd3ea1b62f1da6c1e59b46f7cce1",
      "Article17_questions2_title": "4e0a482a87e84aef069b77d3267dcebb",
      "Article17_questions3_title": "04bb98107c07695ce731b0994c307b8a",
      "Article17_questions3_options0_title": "6e7b34fa59e1bd229b207892956dc41c",
      "Article17_questions3_options1_title": "d5f723e2c82bcdac380b7b027e598752",
      "Article17_questions3_options2_title": "b7fd007b0d920849a5b309d3a86348b1",
      "Article17_questions3_options3_title": "97d085044b0cbe405129de4b7b0ca382",
      "Article17_questions4_title": "038fb9cd6a824a20bf475386c900d34a",
      "Article17_questions4_options0_title": "3a9eb796d66884b422a8f7cee5cff23c",
      "Article17_questions4_options1_title": "a25ee9bd9d8975845690752c140ddcd7",
      "Article17_questions5_title": "c6dd90325ffb1f98393bff4e43dec951",
      "Article17_questions5_options0_title": "7dd10862bc21f13956ac67fd1226ddc3",
      "Article17_questions5_options1_title": "7917c7289bb74f8764046a2fcc2cfe48",
      "Article17_questions5_options2_title": "a4f82052013fb0c8e15e96d6c834b210",
      "Article17_questions6_title": "15743e28f3fbdec9b628f37141583056",
      "Article17_questions6_options0_title": "a05c8bc04b67d979613653210e895247",
      "Article17_questions6_options1_title": "52b54313e436228ef2e0abe5dcb33fce",
      "Article17_questions6_options2_title": "022ea1d7d161c718cfb9a7c6e8258599",
      "Article17_questions6_options3_title": "7ae0a0bd46dbe5afe4742e4916733072",
      "Article17_questions7_title": "59bace90cc484a31aae28d7d369e9edd",
      "Article18": "185d4ba88c940b097092fc1be10acf9e",
      "Article18_title": "73a2945f4584858ea9e8abd116cb4ce4",
      "Article18_questions0_title": "8f476888968dc0930de52565bae839d6",
      "Article18_questions0_options1_title": "cd5db912023c67c1fdf38fb79fbcfa56",
      "Article18_questions1_title": "56f4e9967d8a68266c449318ee274efc",
      "Article18_questions1_options1_title": "cd5db912023c67c1fdf38fb79fbcfa56",
      "Article18_questions2_title": "fdd14b078b1685243ec7fb9842a63022",
      "Article18_questions2_options1_title": "cd5db912023c67c1fdf38fb79fbcfa56",
      "Article18_questions3_title": "50de0849ea3fd934e090b864bf53bd2a",
      "Article18_questions3_options1_title": "cd5db912023c67c1fdf38fb79fbcfa56",
      "Article18_questions4_title": "dd9cae299e9d83e40b2042155f254c91",
      "Article18_questions4_options1_title": "cd5db912023c67c1fdf38fb79fbcfa56",
      "Article18_questions5_title": "4aa559a02dd37fb9540561c7eb7d5bae",
      "Article18_questions5_options1_title": "cd5db912023c67c1fdf38fb79fbcfa56",
      "Article18_questions6_title": "260aafa6a684ddecc7724f9ad8a5398a",
      "Article18_questions6_options1_title": "cd5db912023c67c1fdf38fb79fbcfa56",
      "Article18_questions7_title": "205dc5e16b0cc2ce9b10968fe39d3185",
      "Article19": "f06d22e46d05cb6b78f931cff723a1dc",
      "Article19_title": "0886f1f990c9d7ef3dfd332470016064",
      "Article19_questions0_title": "0006726659a4bc55c71e0a39d53665bd",
      "Article19_questions1_title": "5438c65498d1152b1a72f06487760c19",
      "Article19_questions2_title": "03907dd84f58481c92379ff070421956",
      "Article19_questions2_options0_title": "b52e5e8bfc12e77340671fed3e6a967d",
      "Article19_questions2_options1_title": "f9803ce8917666cccee2a1c9fcda2208",
      "Article19_questions3_title": "03a6191f1a23198bd149f506b2878a06",
      "Article19_questions4_title": "86524e789968461b8989bdd489e8253f",
      "Article19_questions4_options0_title": "a3965f421d80c2da00ebf885bd6ec043",
      "Article19_questions4_options1_title": "0ccdd5a36b54f619db34e85a7b5f6970",
      "Article19_questions5_title": "0d9dce1864f35235d56c41335988bfce",
      "Article19_questions6_title": "28acf278ff1abedad4f829a0bb9e7654",
      "Article19_questions6_options1_title": "cd5db912023c67c1fdf38fb79fbcfa56",
      "Article19_questions7_title": "f828d90230583c21598698e7b8976420",
      "Article20": "b4fa935ebbecf8df81f3ed3e074f698a",
      "Article20_title": "85160db4b117462b084093f7f96b0d1d",
      "Article20_questions0_title": "00f7f99101b14e7b0f75a2c4a3418733",
      "Article20_questions0_options0_title": "fdbbc83d30f1451cce44322548302259",
      "Article20_questions0_options1_title": "47602256623f8eec9d801eba17226309",
      "Article20_questions0_options2_title": "91d0623d65ceaf6225ad491dc2345086",
      "Article20_questions0_options3_title": "de66086497baac3fb32035b9e6a76f3c",
      "Article20_questions1_title": "6ec203f44c2d16101a754ae724dc3c96",
      "Article20_questions1_options0_title": "fdbbc83d30f1451cce44322548302259",
      "Article20_questions1_options1_title": "47602256623f8eec9d801eba17226309",
      "Article20_questions1_options2_title": "91d0623d65ceaf6225ad491dc2345086",
      "Article20_questions1_options3_title": "de66086497baac3fb32035b9e6a76f3c",
      "Article20_questions2_title": "e5280127c47945eddda10faa9cf9e92e",
      "Article20_questions2_options0_title": "fdbbc83d30f1451cce44322548302259",
      "Article20_questions2_options1_title": "47602256623f8eec9d801eba17226309",
      "Article20_questions2_options2_title": "91d0623d65ceaf6225ad491dc2345086",
      "Article20_questions2_options3_title": "de66086497baac3fb32035b9e6a76f3c",
      "Article20_questions3_title": "755ea25d05c96cae8e2f01da3044e6a1",
      "Article20_questions3_options0_title": "fdbbc83d30f1451cce44322548302259",
      "Article20_questions3_options1_title": "47602256623f8eec9d801eba17226309",
      "Article20_questions3_options2_title": "91d0623d65ceaf6225ad491dc2345086",
      "Article20_questions3_options3_title": "de66086497baac3fb32035b9e6a76f3c",
      "Article20_questions4_title": "f1b0c071433c3fe1c966ca374dd975cb",
      "Article20_questions4_options0_title": "fdbbc83d30f1451cce44322548302259",
      "Article20_questions4_options1_title": "47602256623f8eec9d801eba17226309",
      "Article20_questions4_options2_title": "91d0623d65ceaf6225ad491dc2345086",
      "Article20_questions4_options3_title": "de66086497baac3fb32035b9e6a76f3c",
      "Article20_questions5_title": "d2e2ba101d048ccd0133fef57fc9db92",
      "Article20_questions5_options0_title": "fdbbc83d30f1451cce44322548302259",
      "Article20_questions5_options1_title": "47602256623f8eec9d801eba17226309",
      "Article20_questions5_options2_title": "91d0623d65ceaf6225ad491dc2345086",
      "Article20_questions5_options3_title": "de66086497baac3fb32035b9e6a76f3c",
      "Article20_questions6_title": "2ed201328e675bca90cf83f5e639d35b",
      "Article20_questions6_options0_title": "fdbbc83d30f1451cce44322548302259",
      "Article20_questions6_options1_title": "47602256623f8eec9d801eba17226309",
      "Article20_questions6_options2_title": "91d0623d65ceaf6225ad491dc2345086",
      "Article20_questions6_options3_title": "de66086497baac3fb32035b9e6a76f3c",
      "Article20_questions7_title": "1dfb74b6f96f2a3c3bfa25512e5b28ef",
      "Article20_questions7_options0_title": "fdbbc83d30f1451cce44322548302259",
      "Article20_questions7_options1_title": "47602256623f8eec9d801eba17226309",
      "Article20_questions7_options2_title": "91d0623d65ceaf6225ad491dc2345086",
      "Article20_questions7_options3_title": "de66086497baac3fb32035b9e6a76f3c",
      "Article20_questions8_title": "3d299f44f7d17e3a2a9ad005b96804d1",
      "Article20_questions8_options0_title": "fdbbc83d30f1451cce44322548302259",
      "Article20_questions8_options1_title": "47602256623f8eec9d801eba17226309",
      "Article20_questions8_options2_title": "91d0623d65ceaf6225ad491dc2345086",
      "Article20_questions8_options3_title": "de66086497baac3fb32035b9e6a76f3c",
      "Article20_questions9_title": "de494f612f2edaf8dfe098476b3b3e33",
      "Article20_questions9_options0_title": "fdbbc83d30f1451cce44322548302259",
      "Article20_questions9_options1_title": "47602256623f8eec9d801eba17226309",
      "Article20_questions9_options2_title": "91d0623d65ceaf6225ad491dc2345086",
      "Article20_questions9_options3_title": "de66086497baac3fb32035b9e6a76f3c",
      "Article20_questions10_title": "5f46a499421465b31f6dd000b703cc4b",
      "Article20_questions10_options0_title": "fdbbc83d30f1451cce44322548302259",
      "Article20_questions10_options1_title": "47602256623f8eec9d801eba17226309",
      "Article20_questions10_options2_title": "91d0623d65ceaf6225ad491dc2345086",
      "Article20_questions10_options3_title": "de66086497baac3fb32035b9e6a76f3c",
      "Article20_questions11_title": "f08beb08bc4d854a74f09197764efb02",
      "Article20_questions11_options0_title": "fdbbc83d30f1451cce44322548302259",
      "Article20_questions11_options1_title": "47602256623f8eec9d801eba17226309",
      "Article20_questions11_options2_title": "91d0623d65ceaf6225ad491dc2345086",
      "Article20_questions11_options3_title": "de66086497baac3fb32035b9e6a76f3c",
      "Article20_questions12_title": "668eeba7c283715fbfd95043c158998c",
      "Article20_questions12_options0_title": "fdbbc83d30f1451cce44322548302259",
      "Article20_questions12_options1_title": "47602256623f8eec9d801eba17226309",
      "Article20_questions12_options2_title": "91d0623d65ceaf6225ad491dc2345086",
      "Article20_questions12_options3_title": "de66086497baac3fb32035b9e6a76f3c",
      "Article20_questions13_title": "46e5de3de58ce489d96ebacad705b4b1",
      "Article20_questions13_options0_title": "fdbbc83d30f1451cce44322548302259",
      "Article20_questions13_options1_title": "47602256623f8eec9d801eba17226309",
      "Article20_questions13_options2_title": "91d0623d65ceaf6225ad491dc2345086",
      "Article20_questions13_options3_title": "de66086497baac3fb32035b9e6a76f3c",
      "Article20_questions14_title": "7c6855225a1ba75f05c96ee26d23d148",
      "Article20_questions14_options0_title": "fdbbc83d30f1451cce44322548302259",
      "Article20_questions14_options1_title": "47602256623f8eec9d801eba17226309",
      "Article20_questions14_options2_title": "91d0623d65ceaf6225ad491dc2345086",
      "Article20_questions14_options3_title": "de66086497baac3fb32035b9e6a76f3c",
      "Article20_questions15_title": "2edf0979a23d89f5e874ee4f855d1bff",
      "Article20_questions15_options0_title": "fdbbc83d30f1451cce44322548302259",
      "Article20_questions15_options1_title": "47602256623f8eec9d801eba17226309",
      "Article20_questions15_options2_title": "91d0623d65ceaf6225ad491dc2345086",
      "Article20_questions15_options3_title": "de66086497baac3fb32035b9e6a76f3c",
      "Article20_questions16_title": "d03995f9d9467054163ec14192c7b843",
      "Article20_questions16_options0_title": "fdbbc83d30f1451cce44322548302259",
      "Article20_questions16_options1_title": "47602256623f8eec9d801eba17226309",
      "Article20_questions16_options2_title": "91d0623d65ceaf6225ad491dc2345086",
      "Article20_questions16_options3_title": "de66086497baac3fb32035b9e6a76f3c",
      "Article20_questions17_title": "8fbf0c136c69cc8791472bc236543af1",
      "Article20_questions18_title": "9b9d4743484f8a2be8e30698466a228a",
      "Article20_questions19_title": "610e0da518cdeadc5fdff52828e808c5",
      "Article20_questions19_options0_title": "a05c8bc04b67d979613653210e895247",
      "Article20_questions19_options1_title": "52b54313e436228ef2e0abe5dcb33fce",
      "Article20_questions20_title": "ec76e1220008c6611aed983670c3ee26",
      "Article20_questions21_title": "1e355d9550f2e12a0e6ef2993089c540",
      "Article20_questions22_title": "8e7307107d4f24b7dc7a0049227c5007",
      "Article20_questions23_title": "e6be7b2d7c717c3c03bb28ce3b7a17f2",
      "Article21": "803c1e3197d09684f6649ca22ffe4e16",
      "Article21_title": "127af15d1bac1071a6763038e1e39b16",
      "Article21_questions0_title": "b6944eb683ac01be5ca6fe34167e358a",
      "Article21_questions1_title": "b2e2be70f02a29b9feca3f37cff2d125",
      "Article21_questions1_options0_title": "a05c8bc04b67d979613653210e895247",
      "Article21_questions1_options1_title": "701ae6a85673e4f24f000a47e178b8f2",
      "Article21_questions2_title": "97e661d30e898d1ce236d35bd7052dea",
      "Article22": "4a69353a8c3f1cb2cdb2b6eb0722fed6",
      "Article22_title": "c15fa09f019e40522d3dc7ef2a5e0e16",
      "Article22_questions0_title": "2b7c9ec3051371da6afa2a36251fd73b",
      "Article22_questions1_title": "eddeb8c3543dc5abc26cbe59115e2c01",
      "Article22_questions1_options0_title": "7d11f520a5eb1f219d902c9a4ad29944",
      "Article22_questions1_options1_title": "30bdbca82ff4a2f8a149c8e7ebcc9384",
      "Article22_questions1_options2_title": "80769244ba305975b6648a4970fd7d07",
      "Article22_questions2_title": "f4dc40196aa40d3f2fd9300b30574733",
      "Article22_questions3_title": "7102b3d3e59c6d25c123f9a704efa9c5",
      "Article22_questions3_options0_title": "7d11f520a5eb1f219d902c9a4ad29944",
      "Article22_questions3_options1_title": "30bdbca82ff4a2f8a149c8e7ebcc9384",
      "Article22_questions3_options2_title": "80769244ba305975b6648a4970fd7d07",
      "Article22_questions4_title": "5b340568940dc6fee6973b125e914437",
      "Article22_questions5_title": "abdcc6c95726e8860240aa8de10d07d5",
      "Article22_questions6_title": "4099aaf7b3adb52674e3ae253ad63abf",
      "Article22_questions6_options0_title": "4a1fff093480e3ca0b966d2d36ee65ae",
      "Article22_questions6_options1_title": "7f943921724d63dc0ac9c6febf99fa88",
      "Article22_questions6_options2_title": "b1897515d548a960afe49ecf66a29021",
      "Article22_questions6_options3_title": "429ee94cd13d541a0d434e93c798ac4c",
      "Article22_questions6_options4_title": "32464e625ad4e01c9840dff75dea9beb",
      "Article22_questions7_title": "34783e231fe50e24744c01e37a14daed",
      "Article22_questions7_options0_title": "e2192624d4d2903e6936f8af1699e33a",
      "Article22_questions7_options1_title": "165499916ab6a6788b395132b2893671",
      "Article22_questions7_options2_title": "7a56fd72c6cdb1bdb08ddb287e5bf41b",
      "Article22_questions7_options3_title": "c87d5eb1c47edb0c59cb46ee7df5da1c",
      "Article22_questions7_options4_title": "fd9430d1e13fed4ae0d8b8e7c43aa8b3",
      "Article22_questions7_options5_title": "fee7aad8a23efdcd6cfb0f10a07392aa",
      "Article22_questions8_title": "bf51dcba59e7a58e17888bef3d07126f",
      "Article22_questions9_title": "eed07fffa37fbe4de4b8ecebd3107d63",
      "Article22_questions9_options0_title": "ffebb308ac6554a8bc8d7ca2416fa1ef",
      "Article22_questions9_options1_title": "573d44ebe36d0df14ea25555163b2022",
      "Article22_questions9_options2_title": "cea86a75808b0ce7a5c75f2f19b6c4a0",
      "Article22_questions9_options3_title": "78ec87e68f712039dafd856f3bda4a04",
      "Article22_questions9_options4_title": "9f20c61df5c59b7d195300194917ea2d",
      "Article22_questions9_options5_title": "aa23081eb3d431baf509c94d2762197d",
      "Article22_questions9_options6_title": "97b8d82c520be1c2123b1c8050d7b213",
      "Article22_questions9_options7_title": "02a296f22be042b26e2f1c50ff5ffcb0",
      "Article22_questions9_options8_title": "e7244f020f0bf8162a0528cc79118357",
      "Article22_questions9_options9_title": "2840ceea5e41b4804654ec09629f2b29",
      "Article22_questions9_options10_title": "5fe1e7d11c1b20a214a13ae97b82cec6",
      "Article22_questions9_options11_title": "bf9ce9519c142f38af0bc4ab90ed3f2d",
      "Article22_questions9_options12_title": "6d77c17def4f2bad6720b8e9c95df796",
      "Article22_questions9_options13_title": "92b18031c5c30767c0ccac8a384041ad",
      "Article22_questions9_options14_title": "3351fd5d09602422863ae0fd459e7d10",
      "Article22_questions10_title": "ab43ebed5e2bd88a3e0113e791ddef4f",
      "Article22_questions11_title": "a213f4d7bba084d6eb7a6bfa3fc9c4bb",
      "Article22_questions11_options1_title": "7a05b7716f9f958b385f035838ef5cf8",
      "Article22_questions12_title": "092577e366752d300a9b7511aa6b98bd",
      "Article22_questions12_options0_title": "ffebb308ac6554a8bc8d7ca2416fa1ef",
      "Article22_questions12_options1_title": "573d44ebe36d0df14ea25555163b2022",
      "Article22_questions12_options2_title": "cea86a75808b0ce7a5c75f2f19b6c4a0",
      "Article22_questions12_options3_title": "78ec87e68f712039dafd856f3bda4a04",
      "Article22_questions12_options4_title": "9f20c61df5c59b7d195300194917ea2d",
      "Article22_questions12_options5_title": "aa23081eb3d431baf509c94d2762197d",
      "Article22_questions12_options6_title": "97b8d82c520be1c2123b1c8050d7b213",
      "Article22_questions12_options7_title": "02a296f22be042b26e2f1c50ff5ffcb0",
      "Article22_questions12_options8_title": "e7244f020f0bf8162a0528cc79118357",
      "Article22_questions12_options9_title": "2840ceea5e41b4804654ec09629f2b29",
      "Article22_questions12_options10_title": "5fe1e7d11c1b20a214a13ae97b82cec6",
      "Article22_questions12_options11_title": "bf9ce9519c142f38af0bc4ab90ed3f2d",
      "Article22_questions12_options12_title": "6d77c17def4f2bad6720b8e9c95df796",
      "Article22_questions12_options13_title": "92b18031c5c30767c0ccac8a384041ad",
      "Article22_questions12_options14_title": "3351fd5d09602422863ae0fd459e7d10",
      "Article22_questions13_title": "9cb1ac7b0d301d059e706cbe2493f680",
      "Article22_questions14_title": "102609653fd1dd5982e7e3663514f80e",
      "Article22_questions15_title": "3a052851c0168b5476a357202bc60c39",
      "Article23": "269332cb873adfd36ecad5359b2accd7",
      "Article23_title": "55a5b921b68d7137ba4ac2027e31433a",
      "Article23_questions0_title": "04e917621b2f1cbf737001c56a3ffbc8",
      "Article23_questions0_options1_title": "cd5db912023c67c1fdf38fb79fbcfa56",
      "Article23_questions1_title": "9efc1a4dc80bf2be2596f01a2dc59aed",
      "Article23_questions2_title": "d6e2d8eec6b74daeba715a50e7f53618",
      "Article23_questions2_options1_title": "a57165712514446df4f2ef13837d303f",
      "Article23_questions3_title": "1f0f67c9b34517ce4be5e3c72374faff",
      "Article23_questions3_options1_title": "a57165712514446df4f2ef13837d303f",
      "Article23_questions4_title": "85bead1c422f64e9943467facd286002",
      "Article23_questions4_options1_title": "a57165712514446df4f2ef13837d303f",
      "Article23_questions5_title": "6c2285589bb39e8a6705a66f714fc582",
      "Article23_questions6_title": "50da48cd2858bf16f5cbf580d5bb0972",
      "Article23_questions6_options1_title": "a57165712514446df4f2ef13837d303f",
      "Article23_questions7_title": "4153669c27d412c34228a617c6f6c4d8",
      "Article23_questions8_title": "caaa4e9ca709e4cdb64542eb2e6b1ad7",
      "Article23_questions8_options1_title": "d5f723e2c82bcdac380b7b027e598752",
      "Article23_questions8_options2_title": "7e66620b31cefb033e4ca560d32be5e1",
      "Article23_questions9_title": "97a5291ce62c7d6fd81c849852fdb493",
      "Article24": "84ce1f1dd6684e165794e32683f70b37",
      "Article24_title": "f51bf267c189c09b7e70fcdab27f6b9f",
      "Article24_questions0_title": "21d2391f6ea194a86106cdecdc290f5a",
      "Article24_questions1_title": "80ac3091d390f4667df8ffad0852deaa",
      "Article24_questions2_title": "d2114950b1396519a04f447810b4483b",
      "Article24_questions3_title": "d06d72359ff79ec226a044823afecce9",
      "Article24_questions3_options0_title": "a05c8bc04b67d979613653210e895247",
      "Article24_questions3_options1_title": "701ae6a85673e4f24f000a47e178b8f2",
      "Article24_questions4_title": "f35c78a429537ff77358f1410875fc11",
      "Article24_questions4_options0_title": "a05c8bc04b67d979613653210e895247",
      "Article24_questions4_options1_title": "701ae6a85673e4f24f000a47e178b8f2",
      "Article24_questions5_title": "06ce517abc6a9aa7c2c282d07dc67b64",
      "Article24_questions5_options0_title": "a05c8bc04b67d979613653210e895247",
      "Article24_questions5_options1_title": "701ae6a85673e4f24f000a47e178b8f2",
      "Article24_questions6_title": "fa7c12009c68a307881549bb1f8ede24",
      "Article25": "31b76ebec97e4c3f63002c39ec8630dc",
      "Article25_title": "dd3085a0b45dc3b814a7cb87d4dd793f",
      "Article25_questions0_title": "3febfc9d4c368cd7d7b31f01e0a0186a",
      "Article25_questions1_title": "bb9e2ac8f0aea404a843600bec5d5c4c",
      "Article25_questions2_title": "eecf9397443c36226ed972d512c7b944",
      "Article25_questions2_options0_title": "6e7b34fa59e1bd229b207892956dc41c",
      "Article25_questions2_options1_title": "d5f723e2c82bcdac380b7b027e598752",
      "Article25_questions2_options2_title": "b7fd007b0d920849a5b309d3a86348b1",
      "Article25_questions2_options3_title": "97d085044b0cbe405129de4b7b0ca382",
      "Article25_questions3_title": "ee484787933d82cb6c2d4f676610f5bd",
      "Article25_questions3_options1_title": "776c1a2f9fce597e6bcdc9b7005f60fb",
      "Article25_questions3_options2_title": "1a60249c05e0211c3c196b11919dbdbd",
      "Article25_questions3_options3_title": "89e83fe8100c6be1f9ddff1730811d15",
      "Article25_questions4_title": "95d7ff2f5320f5cebf0956bf37180b44",
      "Article25_questions4_options1_title": "4ab327029a59952cda58bba7f7aa2c90",
      "Article25_questions5_title": "060f90b5c450fd5fccda1e6153e15e98",
      "Article25_questions5_options1_title": "4ab327029a59952cda58bba7f7aa2c90",
      "Article25_questions6_title": "1853063a34fdaf2ba8179874ab521149",
      "Article25_questions6_options1_title": "4ab327029a59952cda58bba7f7aa2c90",
      "Article25_questions7_title": "47e3559e8861c757d6255a739b229b62",
      "Article26": "c9b13d4c16a23bed65f9bd2cda046a57",
      "Article26_title": "ce8fe443028ca43b0f67e8ee123b5321",
      "Article26_questions0_title": "749f8cf2f8cd74d865a3f1152c0860a5",
      "Article26_questions0_options1_title": "776c1a2f9fce597e6bcdc9b7005f60fb",
      "Article26_questions0_options3_title": "e681a3b45989b468533c4b90ee960bf9",
      "Article26_questions1_title": "cf31ed582bfd02715146b1efe316cf83",
      "Article26_questions1_options1_title": "a57165712514446df4f2ef13837d303f",
      "Article26_questions2_title": "3f8cb47281cc92d06dd43c68e0ec8fd2",
      "Article27": "09113f774f6390d1904fa104ffc8376a",
      "Article27_title": "6623100baa4ba60f33678d55302f2781",
      "Article27_questions0_title": "c8bfd9d43bf7aabae38bb21f743cfc80",
      "Article27_questions1_title": "68b5d316a1337c18b2e787f21d670ede",
      "Article27_questions2_title": "20965b7776173ac9bab82094c82a9b39",
      "Article33": "386dcbf088b6e4aa427aedc195fe3886",
      "Article33_title": "8841124073befa522a22cbd8ede760be",
      "Article33_questions0_title": "9db5804fd48a6ef01a6baa0e4e0853b4",
      "Article33_questions0_options1_title": "22be1bd6bffd123437c37d40565a5e43",
      "Article33_questions0_options2_title": "3c9be4deb4f1d5f2c795ebb92699500d",
      "Article33_questions1_title": "52fdb77dc9eacaf55e6b6d885728a455",
      "Article33_questions1_options0_title": "4a666cc301660f82f96571644e18f34e",
      "Article33_questions1_options1_title": "55172f0a3084be1e344da9c548bec472",
      "Article33_questions1_options2_title": "ebc76a8430e285ccb0c03c9758ae354b",
      "Article33_questions1_options3_title": "74f9d4cccaa5c8318777827d16e12772",
      "AdditionalInformation": "bdab2032bbe37ec6717f7e6ffbeb15e5",
      "AdditionalInformation_title": "1d2e7006048aec610a44d2592586470b",
      "AdditionalInformation_questions0_title": "c7b96a283ed55358d9f9d04d4d6d35a7",
      "Comments": "8413c683b4b27cc3f4dbd4c90329d8ba",
      "Comments_title": "64d103e6258bb8ebcfbb13727fd31701",
      "Comments_questions0_title": "becc6f3cf1a7526bb3fe411f92e2cbcf",
      "Survey": "9fd9f9ccd630cd4b6894051c35710572",
      "Survey_title": "03abf5770795f7d9a7e63f260608a486",
      "Survey_questions0_title": "eac204db5d2a5e6b1ce438ee0d034ec8",
      "Survey_questions0_options0_title": "9392151098a22a8ce282140f3e93ff28",
      "Survey_questions0_options1_title": "4ba29b9f9e5732ed33761840f4ba6c53",
      "Survey_questions0_options2_title": "a591024321c5e2bdbd23ed35f0574dde",
      "Survey_questions0_options3_title": "b8b4b727d6f5d1b61fff7be687f7970f",
      "Survey_questions0_options4_title": "d47268e9db2e9aa3827bba3afb7ff94a",
      "Survey_questions0_options5_title": "ea5a486c712a91e48443cd802642223d",
      "Survey_questions0_options6_title": "a00e5eb0973d24649a4a920fc53d9564",
      "Survey_questions0_options7_title": "ef8446f35513a8d6aa2308357a268a7e",
      "Survey_questions0_options8_title": "f1981e4bd8a0d6d8462016d2fc6276b3",
      "Survey_questions0_options9_title": "d7a84628c025d30f7b2c52c958767e76",
      "Survey_questions0_options10_title": "c8758b517083196f05ac29810b924aca",
      "Survey_questions0_options11_title": "253614bbac999b38b5b60cae531c4969",
      "Survey_questions0_options12_title": "8038da89e49ac5eabb489cfc6cea9fc1",
      "Survey_questions0_options13_title": "cee8d6b7ce52554fd70354e37bbf44a2",
      "Survey_questions1_title": "c6c7b48cd4724bdaffc34a10711345b7",
      "Survey_questions1_options1_title": "f4bc01750530293897a3f9ff50c0e4d6",
      "Survey_questions1_options2_title": "2ff19b4abe8f269804c629a6a34f17cb",
      "Survey_questions1_options3_title": "51285aa99bbaae7449404d0224be6aed",
      "Survey_questions1_options4_title": "9dfd425180d039acc6b636a4ba6867fd",
      "Survey_questions2_title": "e5d32aa3a7c7de9747b9719b2dfcb876",
      "Survey_questions3_title": "e4d0b275253dfe77c83cd8fc38622d2d",
      "Survey_questions3_options0_title": "e53218b4a37d5368fd9a7d7fc3600da5",
      "Survey_questions3_options1_title": "a7216cb64fa741391cc08fe72fce42c9",
      "Survey_questions3_options2_title": "28a76871d31b2d3baaed1109760d863a",
      "Survey_questions3_options3_title": "db4fba85b67bda27e35203812651057d",
      "Survey_questions3_options4_title": "5df8dbecfd884b42777e8c780972d9b5",
      "Survey_questions3_options5_title": "17c7f468f8841e4dbfe8006a8f71a6c4",
      "Survey_questions3_options6_title": "f0bbcb9c8375cf1d814dbb395f5e7885",
      "Survey_questions4_title": "bebb8ee04ef6cecb389522ef5889198b",
      "Survey_questions5_title": "8517afae315e946b5097b96bb63c89bd",
      "Survey_questions5_options1_title": "10bb9621064f2b73d041868eeea26bd1",
      "Survey_questions5_options2_title": "78bc87c8962c5e9ca68d87f2923662d9",
      "Survey_questions5_options3_title": "689d7b0aa9259bb7fa4b92155a45f825",
      "Survey_questions5_options4_title": "d717af12d953cc1cfa981021acabd019",
      "Survey_questions6_title": "ac1005b33d571a2b7954f9e88efc9db2",
      "Survey_questions7_title": "215c0c9076c1da664f81e3efb6bc0395",
      "Survey_questions8_title": "73956f94c39a186ae708afc991c06365",
      "Survey_questions9_title": "d136e1e7a230ed0d2481328b446743e6",
      "Survey_questions10_title": "d8b9dd60bb6caf1d23721f2f72625e59",
      "Survey_questions11_title": "6f002c4df4a17e0338b64617c09fa3aa",
      "Survey_questions12_title": "5bf0f954a1d7f19ec56d3124cd7b380c",
      "Survey_questions13_title": "c3e67a8b1a343ab8a68161fad538be1d",
      "Survey_questions14_title": "dfa167b7a649acde745ca26387ad02fd",
      "Survey_questions15_title": "adbad1e194256fb303dc7bef630f8649",
      "Survey_questions16_title": "50188fef05c1651d1276d2244d933ecd",
      "Survey_questions16_options1_title": "10bb9621064f2b73d041868eeea26bd1",
      "Survey_questions16_options2_title": "689d7b0aa9259bb7fa4b92155a45f825",
      "Survey_questions16_options3_title": "d717af12d953cc1cfa981021acabd019",
      "Survey_questions16_options4_title": "e87b8f5cf519156917b197402880c86f",
      "Survey_questions17_title": "5b4976d527d938ec29cf7f39acd559c9",
      "Survey_questions18_title": "1d00488b7f63af3072fbcb2858c8ef81",
      "Survey_questions19_title": "ddd7083aac3a711487ba1019a4b42474",
      "Survey_questions19_options1_title": "10bb9621064f2b73d041868eeea26bd1",
      "Survey_questions19_options2_title": "d717af12d953cc1cfa981021acabd019",
      "Survey_questions19_options3_title": "e87b8f5cf519156917b197402880c86f",
      "Survey_questions19_options4_title": "6aaaa80a2c292abba5c0d76f938a439d",
      "Survey_questions20_title": "5c568b1eb21f10e42c7f208886b0c007",
      "Survey_questions20_options1_title": "10bb9621064f2b73d041868eeea26bd1",
      "Survey_questions20_options2_title": "d717af12d953cc1cfa981021acabd019",
      "Survey_questions20_options3_title": "e87b8f5cf519156917b197402880c86f",
      "Survey_questions20_options4_title": "6aaaa80a2c292abba5c0d76f938a439d",
      "Survey_questions21_title": "198b4439c3515a3ecf3252468e445782",
      "Survey_questions21_options1_title": "10bb9621064f2b73d041868eeea26bd1",
      "Survey_questions21_options2_title": "d717af12d953cc1cfa981021acabd019",
      "Survey_questions21_options3_title": "e87b8f5cf519156917b197402880c86f",
      "Survey_questions21_options4_title": "6aaaa80a2c292abba5c0d76f938a439d",
      "Survey_questions22_title": "2128491a994e847bb7710c36d207609a",
      "Survey_questions23_title": "e3b72911900c9d3f4970f79dfeab6a64",
      "Survey_questions24_title": "0556ddccccc8196c905153420e1855d5",
      "Survey_questions25_title": "0e45c0b2bc270c6e49532185284c12ba",
      "Survey_questions26_title": "4171cee64082be699b3983347da84aa4",
      "Survey_questions26_options1_title": "10bb9621064f2b73d041868eeea26bd1",
      "Survey_questions26_options2_title": "d717af12d953cc1cfa981021acabd019",
      "Survey_questions26_options3_title": "e87b8f5cf519156917b197402880c86f",
      "Survey_questions26_options4_title": "6aaaa80a2c292abba5c0d76f938a439d",
      "Survey_questions27_title": "e49de0b56acc54d1200d4726753e58e6",
      "Survey_questions27_options1_title": "10bb9621064f2b73d041868eeea26bd1",
      "Survey_questions27_options2_title": "d717af12d953cc1cfa981021acabd019",
      "Survey_questions27_options3_title": "e87b8f5cf519156917b197402880c86f",
      "Survey_questions27_options4_title": "6aaaa80a2c292abba5c0d76f938a439d",
      "Survey_questions28_title": "f27d7ec68d8b56b32add26ccd654c89f",
      "Survey_questions29_title": "08369648e892b8f6e80faf6ed79a679d",
      "Survey_questions29_options1_title": "10bb9621064f2b73d041868eeea26bd1",
      "Survey_questions29_options2_title": "689d7b0aa9259bb7fa4b92155a45f825",
      "Survey_questions29_options3_title": "d717af12d953cc1cfa981021acabd019",
      "Survey_questions29_options4_title": "e87b8f5cf519156917b197402880c86f",
      "Survey_questions30_title": "a5176b451d4489cbd4987bfcdfd8ef51",
      "Survey_questions30_options1_title": "10bb9621064f2b73d041868eeea26bd1",
      "Survey_questions30_options2_title": "689d7b0aa9259bb7fa4b92155a45f825",
      "Survey_questions30_options3_title": "d717af12d953cc1cfa981021acabd019",
      "Survey_questions30_options4_title": "e87b8f5cf519156917b197402880c86f",
      "Survey_questions31_title": "acdbb84adb75953f70bb3f1880caa7fb",
      "Survey_questions32_title": "227b7505e1e4339b4a0aecfdc1cf4b97",
      "Survey_questions33_title": "46c9e2400eddcb64ab039295fa843df9",
      "Survey_questions34_title": "ee92f1034eb826a831a22819af1acd99",
      "Survey_questions34_options0_title": "b74af8a62180f4e9d291357a9938a192",
      "Survey_questions34_options1_title": "13c402efbe0a12ce75e0fbe1fbe07402",
      "Survey_questions34_options2_title": "6bb6d58b728200b4db7d63055275a07d",
      "Survey_questions34_options3_title": "1e00da4389c7b280167680427b48f418",
      "Survey_questions34_options4_title": "4a6468bd8ce63fe0b733318bd1157852",
      "Survey_questions35_title": "7c61d74cbda8d2ff63ba272f7eff7ef5",
      "Survey_questions35_options0_title": "b74af8a62180f4e9d291357a9938a192",
      "Survey_questions35_options1_title": "13c402efbe0a12ce75e0fbe1fbe07402",
      "Survey_questions35_options2_title": "6bb6d58b728200b4db7d63055275a07d",
      "Survey_questions35_options3_title": "1e00da4389c7b280167680427b48f418",
      "Survey_questions35_options4_title": "4a6468bd8ce63fe0b733318bd1157852",
      "Survey_questions36_title": "dbaa050e33cb4fb36e121f9ec7d0a48a",
      "Survey_questions36_options1_title": "10bb9621064f2b73d041868eeea26bd1",
      "Survey_questions36_options2_title": "78bc87c8962c5e9ca68d87f2923662d9",
      "Survey_questions36_options3_title": "689d7b0aa9259bb7fa4b92155a45f825",
      "Survey_questions36_options4_title": "d717af12d953cc1cfa981021acabd019",
      "Survey_questions37_title": "67016371ba710aa2ca4613bd7d602edb",
      "Survey_questions37_options1_title": "10bb9621064f2b73d041868eeea26bd1",
      "Survey_questions37_options2_title": "689d7b0aa9259bb7fa4b92155a45f825",
      "Survey_questions37_options3_title": "d717af12d953cc1cfa981021acabd019",
      "Survey_questions37_options4_title": "37bf66299552845fe34d6fe725747242",
      "Survey_questions37_options5_title": "6aaaa80a2c292abba5c0d76f938a439d",
      "Survey_questions38_title": "f20d0e8ce9dde4a7d6e9b98ccd443fb0",
      "Survey_questions39_title": "b62868a9919b1792df284ef8c28cbbbd",
      "Survey_questions40_title": "7bfaba516a1f7e4ede6c8c2f05ecead2",
      "Survey_questions40_options1_title": "10bb9621064f2b73d041868eeea26bd1",
      "Survey_questions40_options2_title": "689d7b0aa9259bb7fa4b92155a45f825",
      "Survey_questions40_options3_title": "d717af12d953cc1cfa981021acabd019",
      "Survey_questions40_options4_title": "37bf66299552845fe34d6fe725747242",
      "Survey_questions41_title": "d5670d5001ba4df87af6d16d4bcf6b18",
      "Survey_questions41_options1_title": "10bb9621064f2b73d041868eeea26bd1",
      "Survey_questions41_options2_title": "d717af12d953cc1cfa981021acabd019",
      "Survey_questions41_options3_title": "e87b8f5cf519156917b197402880c86f",
      "Survey_questions41_options4_title": "6aaaa80a2c292abba5c0d76f938a439d",
      "Survey_questions42_title": "5774566f46b4afe7821f2dc206e760d2",
      "Survey_questions42_options0_title": "b74af8a62180f4e9d291357a9938a192",
      "Survey_questions42_options1_title": "66d2f68222853e514dfab23b988945ae",
      "Survey_questions42_options2_title": "adc71f6455c24c0b861548d8fa153d3f",
      "Survey_questions43_title": "8ab50742da6d19eb3bff2f590e5afffe",
      "Survey_questions43_options1_title": "10bb9621064f2b73d041868eeea26bd1",
      "Survey_questions43_options2_title": "689d7b0aa9259bb7fa4b92155a45f825",
      "Survey_questions43_options3_title": "d717af12d953cc1cfa981021acabd019",
      "Survey_questions43_options4_title": "37bf66299552845fe34d6fe725747242",
      "Survey_questions44_title": "16b3a15b4a38d6fc38a5335ea7c158c4",
      "Survey_questions45_title": "54e8357ffb6ceeec6808cbad038b97da",
      "Survey_questions46_title": "5163984a20d80f8790316dbc1faca505",
      "Survey_questions47_title": "e8ca4260480413252acc591f82717e9b",
      "Survey_questions47_options1_title": "10bb9621064f2b73d041868eeea26bd1",
      "Survey_questions47_options2_title": "689d7b0aa9259bb7fa4b92155a45f825",
      "Survey_questions47_options3_title": "d717af12d953cc1cfa981021acabd019",
      "Survey_questions47_options4_title": "37bf66299552845fe34d6fe725747242",
      "Survey_questions47_options5_title": "6aaaa80a2c292abba5c0d76f938a439d"
    }
  }
}